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A B S T R A C T
Background
People undergoing multimodal cancer treatment are at an increased risk of adverse events. Physical fitness significantly reduces following
cancer treatment, which is related to poor postoperative outcome. Exercise training can stimulate skeletal muscle adaptations, such as
increased mitochondrial content and improved oxygen uptake capacity may contribute to improved physical fitness.
Objectives
To determine the effects of exercise interventions for people undergoing multimodal treatment for cancer, including surgery, on physical
fitness, safety, health-related quality of life (HRQoL), fatigue, and postoperative outcomes.
Search methods
We searched electronic databases of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, SPORT-
Discus, and trial registries up to October 2018.
Selection criteria
We included randomised controlled trials (RCTs) that compared the effects of exercise training with usual care, on physical fitness,
safety, HRQoL, fatigue, and postoperative outcomes in people undergoing multimodal cancer treatment, including surgery.
Data collection and analysis
Two review authors independently selected studies, performed the data extraction, assessed the risk of bias, and rated the quality of the
studies using Grading of Recommendation Assessment, Development, and Evaluation (GRADE) criteria. We pooled data for meta-
analyses, where possible, and reported these as mean differences using the random-effects model.
1Exercise interventions for people undergoing multimodal cancer treatment that includes surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
Eleven RCTs were identified involving 1067 participants; 568 were randomly allocated to an exercise intervention and 499 to a usual
care control group. The majority of participants received treatment for breast cancer (73%). Due to the nature of the intervention, it
was not possible to blind the participants or personnel delivering the intervention. The risk of detection bias was either high or unclear
in some cases, whilst most other domains were rated as low risk. The included studies were of moderate to very low-certainty evidence.
Pooled data demonstrated that exercise training may have little or no difference on physical fitness (VO2 max) compared to usual
care (mean difference (MD) 0.05 L/min−1, 95% confidence interval (CI) -0.03 to 0.13; I2 = 0%; 2 studies, 381 participants; low-
certainty evidence). Included studies also showed in terms of adverse effects (safety), that it may be of benefit to exercise (8 studies, 507
participants; low-certainty evidence). Furthermore, exercise training probably made little or no difference on HRQoL (EORTC global
health status subscale) compared to usual care (MD2.29, 95%CI -1.06 to 5.65; I2 = 0%; 3 studies, 472 participants; moderate-certainty
evidence). However, exercise training probably reduces fatigue (multidimensional fatigue inventory) compared to usual care (MD -
1.05, 95% CI -1.83 to -0.28; I2 = 0%; 3 studies, 449 participants moderate-certainty evidence). No studies reported postoperative
outcomes.
Authors’ conclusions
The findings should be interpretedwith caution in view of the lownumber of studies, the overall low-certainty of the combined evidence,
and the variation in included cancer types (mainly people with breast cancer), treatments, exercise interventions, and outcomes. Exercise
training may, or may not, confer modest benefit on physical fitness and HRQoL. Limited evidence suggests that exercise training is
probably not harmful and probably reduces fatigue. These findings highlight the need for more RCTs, particularly in the neoadjuvant
setting.
P L A I N L A N G U A G E S U M M A R Y
Exercise training interventions for people with cancer during cancer treatment before or after surgery
Background
People who are diagnosed with cancer will often undergo intensive treatment in the hope of achieving a cure. Such treatments may
include surgery, chemotherapy, and chemoradiotherapy, frequently given in combination. These treatments can cause side effects
(adverse effects), for example, making people feel less fit and more tired, and decreasing their quality of life. These adverse effects may
be prevented, or at least reduced, if people with cancer undertake an exercise training programme during cancer treatment. In the past,
people with cancer were told to rest, but current recommendations are to stay as active as possible.
Review question
In adult patients undergoing cancer surgery, what is the impact of exercise training versus usual care on fitness, safety, quality of life,
fatigue (tiredness), and clinical outcomes?
Key results
We included 11 studies involving 1067 participants, published up until October 2018. Themajority of people (73%) received treatment
for breast cancer. Participants were randomly assigned to receive an exercise programme or usual care (no exercise training). The
included studies suggested that exercise training may make little or no difference to physical fitness levels. The included studies also
highlighted that it is probably safe to exercise, as the number of adverse events were low. The findings also showed that exercise training
may make little or no difference to quality of life, but that it probably reduces fatigue (tiredness). We do not know whether it improves
postoperative recovery, as no study reported this.
Quality of the evidence
The overall quality (certainty) of the evidence was moderate to very low for all of the outcomes, mainly because of the small number
of studies and low number of participants, as well as study limitations.
Conclusion
The findings of this review should be interpreted with caution due to the overall low-certainty of the evidence, variation in cancer
types and treatments, exercise interventions, and outcomes measured. We are moderately certain that exercise training during adjuvant
treatment (chemotherapy or radiotherapy treatment after surgery) reduces fatigue.
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This is a new area of research, and more information is needed to help us understand whether exercise benefits people undergoing cancer
treatment. Future studies should also concentrate on people with a new diagnosis of cancer who have chemotherapy or radiotherapy
prior to surgery (known as neoadjuvant treatment), to tell us whether exercise training prior to surgery is important.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
The effects of an exercise intervention compared to a usual care control group with people with cancer undergoing multimodal treatment?
Patient or population: People with cancer undergoing mult imodal treatment including surgery
Setting: Hospital/ community
Intervention: Exercise intervent ion
Comparison: Usual care
Outcomes Anticipated absolute effects∗ (95% CI) of participants
(studies)
Certainty of the evidence
(GRADE)
Comments
Risk with usual care control Risk with Exercise
Physical f itness
assessed with: VO2 max (L/
m in)
follow up: range 6 weeks to
24 weeks
The mean post-intervent ion
VO2 max in the usual care
control groups ranged f rom
1.5 to 1.88 L/ m in−1.
The mean post-intervent ion
VO2 max in the intervent ion
group ranged f rom 1.55 to
1.96 L/ m in−1.
MD 0.05, 95% CI -0.03 to 0.
13
381
(2 studies)
⊕⊕©©
LOW 1
Safety
follow up: range 5 weeks to
12 months
Seven studies reported no
adverse events and one
study reported that a part ic-
ipant with a brain tumour ex-
periences a grade 3 seizure
af ter exercise training
507
(8 studies)
⊕⊕©©
LOW 2
HRQoL
assessed with: EORTC
global health status sub-
scale (higher is better)
Scale f rom: 0 to 100
follow up: range 6 weeks to
24 weeks
The mean post-intervent ion
HRQoL score in the usual
care control group ranged
f rom 63.3 to 74
The mean post-intervent ion
HRQoL score in the inter-
vent ion group ranged f rom
67.2 to 75.8
MD 2.29, 95% CI -1.06 to 5.
65.
472
(3 studies)
⊕⊕⊕©
MODERATE 4
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Fatigue
assessed with: Mult idimen-
sional fat igue inventory
(lower is better)
Scale f rom: 0 to 20
follow up: range 18 weeks
to 24 weeks
The mean post-intervent ion
fat igue score in the usual
care control group ranged
f rom 11.9 to 14.7
The mean post-intervent ion
fat igue score in the inter-
vent ion group ranged f rom
11.1 to 13.4, 1.05 lower then
the usual care control group
(95% CI -1.83 to -0.28)
449
(3 studies)
⊕⊕⊕©
MODERATE 5
Postoperat ive outcome No studies reported postoperat ive outcome (0 studies)
CI: Conf idence interval; MD: Mean dif ference
GRADE Working Group grades of evidence
High certainty: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded 2 levels due to indirectness (the study by Adamsen included various cancer treatments and 52%of part icipants
did not have cancer) and imprecision (small sample size).
2 Downgraded 2 levels due to risk of bias (the study by Choi rated as high risk of allocat ion concealment bias and the
study by Hwang was rated as unclear and the study by Husebo was rated as high risk for attrit ion bias) and indirectness
(Adamsen study included various cancer treatments and 52%of part icipants did not have cancer which makes results dif f icult
to interpret. Haines study included a sham intervent ion group).
3 Downgraded 3 levels due to risk of bias (the study by Choi rated as high risk of allocat ion concealment bias and the study
by Chandwani as unclear risk, whilst the study by Chandwani, Husebo and Reis were rated as high risk for attrit ion bias),
inconsistency (large variat ion in results) and indirectness (dif f erent cancer types and treatment).
4 Downgraded 1 level due to indirectness (Adamsen study included various cancer treatments were included and 52% of
part icipants did not have cancer which makes results dif f icult to interpret. Haines study included a sham intervent ion group)
5 Downgraded 1 level due to indirectness (Haines study included a sham intervent ion group)
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B A C K G R O U N D
Description of the condition
People with cancer are often faced with a multimodality treatment
regimen that includes surgery in combination with other treat-
ments, such as chemotherapy, radiotherapy, and immunotherapy.
These treatments are of two kinds: adjuvant treatment is given
after surgery to treat residual disease, in order to minimise the
likelihood of tumour recurrence or spread (Papadimitriou 2015),
whereas the aim of neoadjuvant treatment is to reduce tumour
bulk prior to surgery, in order to improve the likelihood of optimal
surgical resection of the cancer (Chau 2006). Major surgery is as-
sociated with significant morbidity andmortality, as recently high-
lighted in the European Surgical Outcome Study (International
Surgical Outcomes Study group 2017), and morbidity has a ma-
jor impact on postoperative recovery, quality of life, and survival
(Khuri 2005; Moonesinghe 2014).
Cancer is frequently associated with cachexia (body weakness
and wasting), which can worsen perioperative outcomes (Brown
1991). This condition can be exacerbated by chemotherapy, which
is associated with muscle wasting and dysfunction. Furthermore,
cancer treatment has been linked to decreased physical fitness, ap-
parently related to the type of treatment, being worse in those re-
ceiving surgery and radiotherapy in combination with chemother-
apy than in those receiving radiotherapy or surgery alone (Moros
2010). Moreover, this decrease in physical fitness may persist. In
a series of studies, cardiorespiratory fitness was around 30% be-
low that of age-matched sedentary healthy women up to three
years following completion of adjuvant treatment for breast cancer
(Jones 2007). Poor physical fitness reflects reduced physiological
reserve, which predisposes people undergoing surgery to postop-
erative complications (Hennis 2012; Moran 2016; West 2011).
Description of the intervention
For the purposes of this review, we defined an exercise intervention
as a prescribed period of aerobic physical activity, involving large
muscle groups, with a minimum of three planned exercise sessions
in total, each session lasting at least 10minutes (O’Doherty 2013).
The intervention may take place in any setting and be delivered
to a group or to an individual participant. However, it must be
supervised or delivered by a trainer or healthcare professional.
How the intervention might work
Higher physical fitness has been associated with improved progno-
sis in people with solid tumours (Jones 2013), longer cancer-spe-
cific survival, and lower cancer-related mortality (Brunelli 2014).
Remaining physically active during and after cancer treatment
could therefore be an important way of reducing associated ad-
verse effects, improving overall survival, and reducing the rate of
tumour recurrence (Thomas 2014). It has been shown that women
with non-metastatic colorectal cancer who were physically active
following diagnosis had a significantly lower risk of death than
those whowere not physically active (Meyerhardt 2006). Similarly,
women with breast cancer who exercised at moderate intensity
(i.e. at least 30 minutes per day on at least five days per week) were
shown to have a reduced risk of death (Holmes 2005). Exercise
has been shown to be safe for cancer survivors and significantly
improves aerobic fitness (Turner 2018). Exercise training stimu-
lates skeletal muscle adaptations such as increased mitochondrial
(cell energy source) content and improved oxygen uptake capacity,
both contributors to physical fitness (Holloszy 1984). In combi-
nation with chemotherapy, exercise training has been shown to
slow tumour progression in solid tumours compared with che-
motherapy alone (Betof 2015). Exercise may also reduce chronic
inflammation, which has been associated with worse outcomes in
people living with cancer (Proctor 2011).
Why it is important to do this review
Studies in people undergoing multimodal cancer treatment, in the
form of neoadjuvant chemotherapy, chemoradiation, and surgery
for upper and lower gastrointestinal cancer, suggest that the re-
duced physical fitness associated with these treatment modalities
may be linked to higher in-hospital morbidity and mortality at
one year post-treatment (Jack 2014; West 2014). The literature
covering the effects of an exercise intervention to improve physi-
cal fitness in people with cancer undergoing single modality treat-
ment has been synthesised in a number of systematic reviews.
Two systematic reviews in people with non-small cell lung cancer
(NSCLC) reported beneficial effects on physical fitness and other
important clinical measures following participation in an exer-
cise intervention in people who were treated surgically (Crandall
2014), and beneficial effects on physical fitness, symptoms and
health-related quality of life (HRQoL) in people who were treated
by surgery or a form of cancer treatment (Granger 2011). Two
other systematic reviews in people with cancer (different cancer
types) found evidence that exercise training in people who were
surgically treated improved urinary continence (in prostate can-
cer), cardiorespiratory fitness, length of stay (Singh 2013), and
HRQoL in people who received cancer treatment (Mishra 2012).
However, to the best of our knowledge, there are no systematic
reviews specifically addressing the effects of an exercise interven-
tion on physical fitness and other important clinical outcomes in
people with cancer undergoing multimodality treatment that in-
cludes surgery.
O B J E C T I V E S
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To determine the effects of exercise interventions for people un-
dergoing multimodal treatment for cancer, including surgery, on
physical fitness, safety, health-related quality of life (HRQoL), fa-
tigue, and postoperative outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered only randomised controlled trials (RCTs) for in-
clusion.
Types of participants
We included studies that evaluated the effects of an exercise in-
tervention in adults (18 years and over) with a confirmed cancer
diagnosis requiring multimodal cancer treatment that included
surgery,regardless of gender, tumour type, tumour stage, and type
of cancer treatment, and of any exercise/activity level.
Types of interventions
We included any exercise intervention that involved a prescribed
period of aerobic physical activity, involving large muscle groups,
with a minimum of three planned exercise sessions, each session
lasting at least 10 minutes, delivered by trained personnel or a
healthcare professional. The intervention could take place in any
setting and be delivered to a group or to an individual partici-
pant. We included studies of exercise counselling interventions or
prescribed exercise only, such as prescribed daily walking. We ex-
pected the interventions would vary to some extent with regard to
the timing of initiation, duration, and content.
Types of outcome measures
Primary outcomes
• Physical fitness (aerobic fitness measured by: VO2 max, 6-
minute walk distance test (MWD), 12 MWD, maximal short
exercise capacity test, endurance time test, step test; strength
(upper and lower body) measured by: grip strength test, chest
press test, pull down test, elbow flexion test, 1-repetition max (1-
RM), leg press test, 30-second chair-stand test, knee extension
test and; physical activity (physical activity monitors or
questionnaires).
Secondary outcomes
• Safety (number of adverse events).
• HRQoL (European Organisation for Research and
Treatment of Cancer (EORTC QLQ-C30), EQ-5D, Short Form
Health Survey (SF-36), World Health Organisation Quality of
Life (WHOQOL) and Functional Assessment of Chronic Illness
Therapy-Fatigue (FACIT-F).
• Fatigue (EORTC fatigue subscale, multidimensional fatigue
inventory, Brief Fatigue Inventory (BFI), Schwartz Cancer
Fatigue scale, Piper Fatigue Scale (PFS) and FACIT-F).
• Postoperative outcomes (morbidity, disease-free survival at
12 months, and overall survival at five years).
Search methods for identification of studies
Electronic searches
We searched the following electronic databases to obtain relevant
studies for this review up until October 2018:
• the Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 10), in the Cochrane Library
(Appendix 1);
• MEDLINE via Ovid (1946 to September week 3, 2018)
(Appendix 2);
• Embase via Ovid (1980 to 2018 week 40) (Appendix 3);
• SPORTDiscus (1980 to October 2018) (Appendix 4).
We applied no language or date restrictions in the searches.
Searching other resources
We performed an expanded search for articles to identify ’grey
literature’, which included:
• Handsearching of reference lists of all articles, texts, and
other review articles on exercise and cancer;
• PubMed: ’Related articles’ feature;
• Web of Science: citation search of key authors;
• Clinical trials registers search: Clincaltrials.gov and the
WHO International Clinical Trials Registry Platform (
apps.who.int/trialsearch/) for ongoing trials and trial protocols;
• Unpublished literature through searches of conference
proceedings;
• Attempts to contact study authors for missing data and
information related to study methods.
Data collection and analysis
Selection of studies
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Two authors (LL and MAW) imported all records retrieved from
the searches into the reference management software package
EndNote. We then removed duplicates and selected relevant arti-
cles for screening.We examined the remaining references indepen-
dently and excluded those studies which did not clearly meet the
inclusion criteria. We then obtained full-text copies of potentially
relevant references and any disagreements were resolved through
discussion or, if required, by a third review author (SJ). We linked
together multiple records on the same study and documented the
selection process in the Covidence web-based software platform.
We excluded case reports and theses.
Data extraction and management
Two authors (LL and MAW) independently extracted study char-
acteristics and outcome data, in accordance with predefined crite-
ria, to a data collection form. We retrieved full texts of all studies
in which the abstract referred to an exercise intervention in peo-
ple with cancer, and studies for which there was no abstract but
the title suggested relevance. We noted in the Characteristics of
included studies table, if outcome data were not reported in a us-
able way. One review author (LL) transferred data into the Review
Manager 2014 (RevMan) software and double-checked that the
data were entered correctly by comparing the data entered into
RevMan with the study reports. A second review author (MAW)
did a spot-check of study characteristics for accuracy against the
trial report. For included studies, the followingdatawere extracted:
Study details
• study design, methodology;
• methods of recruitment of participants;
• study aim;
• study start and end date (study duration);
• author, country, and year of publication;
• sample size;
• duration of follow-up;
• study funding source;
• declarations of conflict of interest.
Participant characteristics
• inclusion criteria;
• exclusion criteria;
• baseline imbalances;
• total number randomised;
• number of participants in intervention group;
• number of participants in the control group;
• age;
• gender;
• race/ethnicity;
• cancer type;
• cancer treatment;
• attrition rate at specified follow-up time points;
• reasons for withdrawal.
Intervention details
• setting (in-hospital, community-based, home-based);
• exercise prescription components (frequency, intensity,
time, type);
• monitoring during exercise;
• adherence;
• adverse events.
Comparison details
• description of usual care control groups;
• additional information, if appropriate.
Outcomes
• primary and secondary outcomes
◦ method of outcome measurement and time point of
outcome measurement.
Assessment of risk of bias in included studies
Two authors independently assessed and scored the methodolog-
ical quality of each study in accordance with the Cochrane tool
for assessing risk of bias (Higgins 2011). This tool includes the
following seven domains:
• random sequence generation;
• allocation concealment;
• blinding of participants and personnel;
• blinding of outcome assessment;
• incomplete outcome data;
• selective reporting;
• other potential sources of bias.
Two authors (LL and MAW) independently applied the ’Risk of
bias’ tool , and resolved differences by discussion with a third
review author (SJ). Results were summarised in both a ’Risk of bias’
graph (Figure 1) and a ’Risk of bias’ summary figure (Figure 2).We
scored each item according to the criteria set out by Higgins 2011,
and provided a quote from the study report and/or a statement of
justification for the judgement for each item in the ’Risk of bias’
table. When interpreting treatment effects, two authors took into
account the risk of bias for the studies that contributed to that
outcome.
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Figure 1. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
9Exercise interventions for people undergoing multimodal cancer treatment that includes surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Measures of treatment effect
Both primary and secondary outcomes (e.g. physical fitness,
HRQoL, fatigue) are continuous outcomes. For these, we recorded
mean and standard deviation (SD) at baseline and post-interven-
tion values of the outcome of interest and the number of partici-
pants assessed at stated follow-up in each treatment arm. For the
other secondary outcome, safety, we reported it as number of ad-
verse events.
Unit of analysis issues
All trials were two-armed except for two studies which were
three-armed (Chandwani 2014; VanWaart 2015). However, the
“stretching intervention” arm in the study by Chandwani 2014
was not reported as it was not classed as an exercise intervention.
The study by VanWaart 2015 included two exercise intervention
arms (home and supervised exercise groups). We extracted data
from relevant arms, and compared the intervention arms versus
the control group.
Dealing with missing data
When required, we made an attempt to contact study authors
to obtain missing data (participants, intervention, outcome, or
summary data).
Assessment of heterogeneity
Where we considered studies to be similar enough (based on con-
sideration of participants, cancer treatment, exercise training char-
acteristics, or outcome measures), we used clinical expertise to de-
cide whether it was appropriate to combine trials in a meta-analy-
sis. We assessed the degree of heterogeneity by visual inspection of
forest plots, by estimation of the percentage of heterogeneity (I²
measurement) between trials which could not be ascribed to sam-
pling variation (Higgins 2003), by a formal statistical test of the
significance of the heterogeneity (Chi²) (Deeks 2001) and, where
possible, by subgroup analyses. We regarded heterogeneity as sub-
stantial if I² was greater than 30% and either Tau² was greater
than zero, or there was a low P value (< 0.10) in the Chi² test for
heterogeneity.
Where we had concerns regarding clinical, methodological, or sta-
tistical heterogeneity across included studies, we did not report
pooled results frommeta-analysis and reported possible clinical or
methodological reasons for this.
Assessment of reporting biases
If 10 or more studies investigated a particular outcome, we had
planned to examine funnel plots corresponding tometa-analysis of
the primary outcome to assess the potential for small-study effects
such as publication bias.
Data synthesis
Mean differences (MDs) with 95% confidence intervals (CIs)
were calculated by using a random-effects model. Where ap-
propriate, we conducted statistical analysis using a random-ef-
fects model with inverse variance weighting for all meta-analy-
ses (DerSimonian 1986). We considered the random-effects sum-
mary as the average range of possible treatment effects and dis-
cussed the clinical implications of treatment effects differing be-
tween studies. We entered the data of the included studies into
RevMan version 5.3 software (Review Manager 2014). We used
theGRADEcriteria to assess the certainty of the evidence of the in-
cluded studies. We presented results as the average treatment effect
with its 95% CI and the estimates of I2. Data from the following
outcome measures were pooled for meta-analyses: aerobic fitness
(VO2 max (oxygen uptake at maximal capacity), 6-minute walk
distance (6MWD), upper body strength (grip strength), HRQoL
(EORTC QLQ-C30, EQ-5D, SF-36) and fatigue (multidimen-
sional fatigue inventory and EORTC). Where meta-analyses were
not possible, we reported all available effect information from the
included studies in a narrative format.
Subgroup analysis and investigation of heterogeneity
We did not conduct subgroup analyses according to: cancer type,
exercise intervention characteristics, or participant characteristics
due to the small number of studies measuring the same outcomes.
Sensitivity analysis
Where appropriate, we performed sensitivity analyses on the basis
of trial quality by repeating our analysis including only trials that
were of high quality (i.e. we did not include low quality trials
identified using the Cochrane’s tool for assessing risk of bias).
Summary of findings table
Two authors independently rated the certainty of the evidence for
each outcome using GRADE (GRADE Working Group 2004).
A ’Summary of findings’ table was created in GRADEpro GDT.
For assessments of the overall certainty of evidence for each out-
come that included pooled data from RCTs only, we downgraded
the evidence from ’high certainty’ by one level for serious (or by
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two for very serious) study limitations (risk of bias), indirectness
of evidence, serious inconsistency, imprecision of effect estimates,
or potential publication bias. We included the following outcomes
in the Summary of findings for the main comparison:
• physical fitness;
• safety;
• HRQoL;
• fatigue;
• postoperative outcomes (morbidity and survival).
R E S U L T S
Description of studies
Results of the search
Our database search yielded 3802 candidate abstracts, including
56 duplicates. We therefore reviewed 3746 abstracts for potential
inclusion. We excluded 3708 abstracts during the initial title and
abstract screening and assessed 38 studies on the basis of full-text
review. Of these, we excluded 27 studies and 11 studies met the
inclusion criteria. The study flow diagram is shown as Figure 3.
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Figure 3. Study flow diagram.
13Exercise interventions for people undergoing multimodal cancer treatment that includes surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nine ongoing studies were identified through searching other
resources such as clinicaltrials.gov and the WHO International
Clinical Trials Registry Platform (Loughney 2016; Morielli
2018; NCT02159157; NCT02454777; NCT02802826;
NCT02999074; NCT03102866;
NCT03280836; NCT03509428). Characteristics describing the
primary author, methodology, outcomes of interest, intervention,
study start date, and expected end date as well as country of study
conduct are reported in (Characteristics of ongoing studies). Of
the nine ongoing studies, six were breast cancer studies, two col-
orectal cancer, and one included all major cancers. Eight studies
were either not yet recruiting or recruiting, whilst one colorectal
cancer study had closed (results were being prepared for publica-
tion in 2018) (Loughney 2017).
Included studies
We included 11 studies in this review, the majority of which were
studies of women with breast cancer undergoing surgery and ad-
juvant cancer treatment. The studies involved 1067 participants
(73% in breast cancer studies), 568 of whom were randomly al-
located to a form of an exercise intervention for a minimum of
five weeks, while 499 were randomly assigned to a control group.
The individual studies are described in Characteristics of included
studies and further details are given below. All authors of the in-
cluded studies, except two, were contacted about missing data
(Adamsen 2009;Haines 2010), five of which responded to provide
us with additional study information (Chandwani 2014; Husebo
2014; May 2017; Reis 2013; VanWaart 2015).
Study details
The included studies were conducted in different countries.
Four were undertaken in the United States (Battaglini 2007;
Chandwani 2014; Mock 2005; Reis 2013), two studies in Ko-
rea (Choi 2012; Hwang 2008) and Netherlands (May 2017;
VanWaart 2015), while the remaining studies were conducted in
Australia (Haines 2010), Denmark (Adamsen 2009), and Norway
(Husebo 2014).The sample size ranged from 20 to 269: six stud-
ies had sample sizes with fewer than 100 participants (Battaglini
2007; Choi 2012; Haines 2010; Husebo 2014; Hwang 2008;
Reis 2013), three studies had sample sizes between 100 to 200
(Chandwani 2014; May 2017; Mock 2005), while the remaining
two had sample sizes of more than 200 (Adamsen 2009; VanWaart
2015). All studies were two-armRCTs that assigned participants to
an exercise and usual care control group except for two studies that
were three-arm RCTs comprising two intervention arms and one
control arm (Chandwani 2014; VanWaart 2015). The “stretch-
ing intervention” arm in the study by Chandwani 2014 was not
reported as it was not classed as an exercise intervention. For the
purposes of this review, the two intervention arms in theVanWaart
2015 study were referred to as Intervention 1 (On-Track), which
was a supervised hospital-based exercise programme, and Inter-
vention 2 (Onco-Move), which was an unsupervised home-based
programme.
Participants
Cancer types varied across studies: one included 21 different can-
cer types (52% were reported not to have any cancer) (Adamsen
2009), seven included breast cancer (Battaglini 2007; Chandwani
2014;Haines 2010;Husebo 2014;Hwang 2008;Mock 2005;Reis
2013), one stomach cancer (Choi 2012), and two included a com-
bination of breast and colon cancer (May 2017; VanWaart 2015).
Cancer treatments were mainly delivered in the adjuvant setting
but varied across studies. Half of the included studies reported one
type of cancer treatment such as radiotherapy ( Hwang 2008; Reis
2013), or chemotherapy (Battaglini 2007; Choi 2012; VanWaart
2015), while the remaining five reported a mix of cancer treat-
ments: for example, one study reported 59 different chemother-
apy regimens (Adamsen 2009), another study reported adjuvant
treatment but type of cancer treatment was not provided (Haines
2010), while the remaining studies reported chemotherapy, other
systemic treatment, and radiotherapy (Husebo 2014), chemother-
apy and radiotherapy (May 2017), or adjuvant cytotoxic chemo-
therapy/radiation therapy (Mock 2005). The study byChandwani
2014 reported that participants would be randomised according
to chemotherapy (neoadjuvant or adjuvant) among other variables
but details of numbers undergoing either treatment were not re-
ported. The study by May 2017 reported that fewer than 5% un-
derwent neoadjuvant treatment. The age of participants in the in-
cluded studies ranged from 40 to 70 years. There was substantial
gender imbalance, with 73% of the included studies being breast
cancer studies.
Intervention details
Supervised programmes
Six studies included a supervised exercise intervention (Adamsen
2009; Battaglini 2007; Chandwani 2014; Hwang 2008; May
2017; VanWaart 2015), of which three were hospital-based
(Adamsen 2009; Chandwani 2014; May 2017), one based in a
rehabilitation centre (Battaglini 2007), one based in the commu-
nity (VanWaart 2015) and one did not report the setting (Hwang
2008). The exercise intervention was delivered to a group in one
study (Adamsen 2009), on a one-to one basis in three other studies
(Battaglini 2007; Chandwani 2014; VanWaart 2015), while the
remaining two studies did not report this information (Hwang
2008; May 2017).
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The duration of the exercise intervention varied: a 5-week (Hwang
2008), 6-week (Adamsen 2009; Chandwani 2014), 15-week
Battaglini 2007) or 18-week period (May 2017); in one study,
the duration was not clearly reported (“Started with the first cy-
cle of chemotherapy and continued until 3 weeks after the last
cycle”) (VanWaart 2015). The exercise intervention components
also varied across studies and included a combination of aer-
obic, strength, balance, coordination, and relaxation (Adamsen
2009), yoga (Chandwani 2014), aerobic, strength, and stretch-
ing (Hwang 2008), or aerobic and strength (Battaglini 2007;
May 2017; VanWaart 2015). Exercise was prescribed for two ses-
sions per week (Battaglini 2007; May 2017; VanWaart 2015) or
three sessions per week (Adamsen2009; Chandwani 2014;Hwang
2008).
Descriptionof the intensity of aerobic exercise also varied: high and
low intensities (Adamsen 2009), 50% to 70% age-adjusted heart
rate maximum (Hwang 2008), interval intensities (May 2017),
50% to 80% maximal workload (steep ramp test) and by the
BORG scale (rating of perceived exertion) (less than 12 for increase
and more than 16 for a decrease) (VanWaart 2015); while in two
studies the intensity was not clearly reported (Battaglini 2007;
Chandwani 2014).Descriptionof the intensity of strength exercise
varied: 70% to 100% 1-repetition maximum (RM) (Adamsen
2009), 65% 1-RM gradually increasing to reach 1 x 10 repetitions
(75% 1-RM), 20 x repetitions (45% 1-RM) by the end of the
programme (May 2017), 80% 1-RM (VanWaart 2015), and in
one study, the intensity was not clearly reported (Battaglini 2007).
The duration of the exercise programmes varied: 30 to 90 minutes
(min) (Adamsen 2009), 50 min (Hwang 2008; VanWaart 2015),
60 min (Chandwani 2014), or no more than 60 min (Battaglini
2007); the duration was not reported in one study (May 2017).
The type of exercises varied across studies and included cy-
cle ergometer, strength exercises on machines (Adamsen 2009;
Battaglini 2007), as well as body awareness and restoring training
and massage (Adamsen 2009), yoga exercises (Chandwani 2014),
treadmill and bicycling (Hwang 2008), and the type of exercise
was not reported in two studies (May 2017; VanWaart 2015). Ad-
herence to the supervised programmes was 71% (Adamsen 2009;
VanWaart 2015), 83% (May 2017), 87% (Chandwani 2014),
100% (Battaglini 2007), and one study did not report adherence
(Hwang 2008).
Home-based programmes
Six studies included home-based exercise interventions (Choi
2012; Haines 2010; Husebo 2014; Mock 2005; Reis 2013;
VanWaart 2015). The exercise intervention was delivered over
eight weeks (Choi 2012), 12 weeks (Reis 2013) or 12 months
(Haines 2010), where only data for EQ-5D were collected at 12
months (over the telephone), and for other outcome measures,
follow-up assessment was conducted at six months. However, it
must be noted that, in some cases, it was unclear. One study re-
ported that the duration of the programmewas for the period from
initiation to cessation of adjuvant therapy: six weeks of radiother-
apy or three to six months of chemotherapy (Mock 2005). In the
study by Husebo 2014, the exercise intervention was delivered for
the duration of chemotherapy (18 to 24 weeks), however, not all
participants received chemotherapy. One study reported that the
exercise programme “Started with the first cycle of chemotherapy
and continued until 3 weeks after the last cycle” (VanWaart 2015).
The exercise intervention components were also varied, and in-
cluded aerobics (Choi 2012; Mock 2005; VanWaart 2015), aero-
bics, strength, balance, and shoulder mobility (Haines 2010), aer-
obics and strength (Husebo 2014) or aerobics, strength, balance,
yoga, stretching (known as the Nia programme) (Reis 2013).
Exercise was prescribed for three sessions per week (Husebo 2014;
Reis 2013), more than three sessions per week (Choi 2012), five
sessions per week (VanWaart 2015), and five to six times per week
(Mock 2005); in two studies, the frequency of exercise was not
clear (Haines 2010), or not reported (Husebo 2014).
The intensity of the aerobic component was moderate intensity
(Choi 2012; Husebo 2014), with moderate intensity described as
approximately 50% to 70% of maximum heart rate (Mock 2005)
or as a score of 12 to 14 on the BORG scale (VanWaart 2015).
In the study by Reis 2013, intensity was not clear: “The practice
of Nia can be gentle for individuals with a sedentary lifestyle or
challenging for those with an active lifestyle”.
The duration of the exercise intervention varied between 15 to 30
min (Mock 2005), 20 to 60 min (Reis 2013), 30 min (Husebo
2014; VanWaart 2015), 36 min (Haines 2010) or 60 min (Choi
2012). The type of exercise was mainly walking or a combination:
walking (Choi 2012; Mock 2005; VanWaart 2015), walking and
home-based exercises for strength balance and mobility (Haines
2010), or walking and strength-resistant exercises (Mock 2005).
One study did not report the exercise type fully (Reis 2013).
Adherence to home-based programmes was reported by the num-
ber of sessions/percentage and, in some cases, for each exercise
component: 3.8 sessions per week (Choi 2012), or at the three
months median interquartile range (IQR) sessions per patient
with 32 sessions for strength or balance and 22 sessions for en-
durance; while at the six months median (IQR), there were 12 ses-
sions for strength or balance and 13 sessions for endurance (how-
ever this was a 12-month programme and overall adherence was
not reported) (Haines 2010). One study reported adherence to
the aerobic component at 17% and 15% to the strength compo-
nent (Husebo 2014), while other studies reported 55% (VanWaart
2015) and 72% (Mock 2005) to aerobic exercise programmes or
two days per week of the Nia programme plus two sessions per
week of other aerobic exercise (Reis 2013).
Participants assigned to the home-based programmes received sup-
port from research staff throughout the study period. In one study,
a weekly 5 to 10 min telephone conversation was conducted, and
a weekly short (less than 40 characters) message for exercise rein-
forcement was sent to the participant for eight weeks (Choi 2012).
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Two studies reported that a member of the research team tele-
phoned participants, but the timing was not documented (Haines
2010; Husebo 2014). One study reported that the research team
contacted participants every twoweeks to evaluate the prescription
andparticipant progress; furthermore, the exercise programmewas
detailed in a booklet and video to ensure standardisation (Mock
2005). One other study provided participants with an activity di-
ary that was discussed at each chemotherapy cycle, where spe-
cially trained nurses encouraged participants to engage in exercise
(VanWaart 2015). In one study, participants received encourage-
ment from a nurse in the chemotherapy unit to be physical active
at least 30 minutes per day. This encouragement was provided
each time the nurse saw the participant (VanWaart 2015).
Usual care control group details
The usual care control groups generally received no formal exer-
cise training, except in one study, and some other studies provided
participants with exercise advice. In the study by Haines 2010, the
usual care control group was an active sham group which included
a home-based flexibility and relaxation programme. Participants
received a phone call from a member of the research team weekly.
In the study by Hwang 2008, the usual care control group was
shown how to perform a shoulder range of motion exercises and
were encouraged to continue normal activities. In studies by May
2017 and Mock 2005, the usual care control groups were asked
to maintain their current physical activity levels but no formal
exercise programme was provided. Similar advice was provided to
the usual care control group in the study by Reis 2013, except the
control group participants also met individually with the principal
investigator. Participants were instructed to record their activities
in an exercise log. At six-week and 12-week time points, partic-
ipants met individually with the principal investigator to discuss
topics such as physical, emotional, mental, and spiritual well-be-
ing.
Excluded studies
Twenty-seven full-text articles were excluded from the review due
to the following reasons:
• wrong patient population (n = 12) (Ahmed 2006;
Bloomquist 2014; Cadmus 2009; Coleman 2003; Courneya
2009; Devoogdt 2011; Dimeo 1997; McNeely 2008; Mina
2014; Pehlivan 2011; Saxton 2014; Villanueva 2011);
• wrong study design (n = 6) (Cho 2008; Coleman 2003;
Jones 2010; McNeely 2010; Salhi 2014; So 2006);
• wrong setting (n = 5) (Duijts 2012; Harder 2015; Kilbreath
2012; Salhi 2015; Thorsen 2005);
• wrong intervention (n = 2) (Song 2013; Xu 2015);
• wrong study aim (n = 1) Courneya 2008);
• wrong comparator (n = 1) (Courneya 2014).
See characteristics of Excluded studies for an overview.
Risk of bias in included studies
Due to the nature of the intervention, it was expected that blinding
of participants and personnel delivering the interventions would
not be possible. Consequently, risk of performance bias in all stud-
ies was high. Risk of bias for other bias domains varied across
the included studies, and in some studies, insufficient detail was
provided to inform judgement. Where insufficient detail was pro-
vided, all authors were contacted by email. See Figure 1, ’Risk
of bias’ graph, and Figure 2, ’Risk of bias’ summary table, for an
overview.
Allocation
We judged nine studies as being at low risk for random se-
quence generation (Adamsen 2009; Battaglini 2007;Haines 2010;
Husebo 2014; May 2017; Mock 2005; Reis 2013; VanWaart
2015) and one study as high risk (Choi 2012), while the remain-
ing two studies provided insufficient information to inform judge-
ment (Chandwani 2014; Hwang 2008). We judged seven studies
as being at low risk for allocation concealment (Adamsen 2009;
Haines 2010; Husebo 2014; May 2017; Mock 2005; Reis 2013;
VanWaart 2015), one as high risk (Choi 2012), and the remain-
ing three provided insufficient information to inform judgement
(Battaglini 2007; Chandwani 2014; Hwang 2008).
Blinding
Performance bias
Due to the nature of the intervention, risk of performance bias
was high in all studies.
Detection bias
We could only assess six studies for detection bias; three were rated
as low risk (Adamsen 2009; Haines 2010; May 2017), three as
high risk (VanWaart 2015; Reis 2013; Chandwani 2014), while
the remaining five studies provided insufficient information to
inform judgement (Battaglini 2007; Choi 2012; Husebo 2014;
Hwang 2008; Mock 2005).
Incomplete outcome data
We judged eight studies as being at low risk for attrition bias (
Adamsen 2009; Battaglini 2007;Choi 2012;Haines 2010;Hwang
2008; May 2017; Mock 2005; VanWaart 2015), and three as high
risk of bias (Chandwani 2014; Husebo 2014; Reis 2013).
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Selective reporting
We judged three studies as being at high risk for reporting bias
(Battaglini 2007; Mock 2005; VanWaart 2015), and seven as low
risk (Adamsen 2009; Chandwani 2014; Choi 2012; Haines 2010;
Husebo 2014; May 2017; Reis 2013), while the remaining study
provided insufficient information to inform judgment (Hwang
2008).
Other potential sources of bias
We judged four studies as being at high risk for other sources
of bias. Adamsen 2009 included various cancer types, however,
52% of the study population were reported not to have cancer.
The measure of HRQoL reported by Choi 2012 was not clearly
stated. Although reference was made within the study to two other
studies, the references were an unpublished doctoral dissertation
and a master’s thesis. In Haines 2010, the control group was a
sham intervention group. Furthermore, the exercise intervention
was reported as a 12-month intervention. However, all measures,
except EQ-5D, were reported at six months while EQ-5D was
reported at 12 months over the telephone. The study by Battaglini
2007 reported data pre-surgery and post-cancer treatment. No
data were collected following surgery or before cancer treatment,
therefore, these data were not included in the review.
Effects of interventions
See: Summary of findings for the main comparison The effects
of an exercise intervention compared to a usual care control group
with people with cancer undergoing multimodal treatment?
See: Summary of findings for the main comparison for the main
comparisons between the exercise intervention and usual care con-
trol groups.
All outcome results for meta-analyses were based on the earliest
follow-up time point following completion of the exercise inter-
vention. All other outcome results that were not appropriate for
meta-analyses were reported comparing the exercise intervention
and usual care control groups using baseline and earliest follow-
up time point following completion of the exercise intervention.
Primary outcomes
Physical fitness
In this review, physical fitness included any measure of aerobic
fitness and strength, as well as physical activity.
Aerobic fitness
A total of eight studies reported aerobic fitness using a variety of
different outcome measures assessed by: VO2 max test (Adamsen
2009; Battaglini 2007; May 2017); six-minute walk distance test
(6MWD) (Haines 2010; Husebo 2014; Reis 2013); maximal
short exercise capacity test (VanWaart 2015); endurance time test
(VanWaart 2015); step test (Haines 2010); and 12-minute walk
distance test (12MWD) (Mock 2005). Meta-analyses were con-
ducted for VO2 max test and 6MWD.
A meta-analysis was conducted using data from two studies that
reported the VO2 max test using a cycle ergometer (Adamsen
2009; May 2017). In the study by Battaglini 2007, data for VO2
max were not reported. Findings showed that there may be no
difference between the intervention group compared to usual care,
given here as mean difference (MD) 0.05 L/min−1, 95% CI -
0.03 to 0.13, I2 = 0% ; 2 studies, 381 participants; low-certainty
evidence (Analysis 1.1).
A meta-analysis was also conducted using data from studies that
reported the 6MWD (Haines 2010; Husebo 2014; Reis 2013).
Findings showed that there was probably no difference between
the intervention group compared to the usual care group (MD
16.79 metres, 95% CI -7.39 to 40.96, I2 = 0%; 3 studies, 146
participants; moderate-certainty evidence) (Analysis 1.2).
Aerobic fitness data from individual studies
A narrative description of all other outcome results, reported be-
low, are presented in Table 1.
In the study by VanWaart 2015, there was a significant differ-
ence in the maximal short exercise capacity test from baseline to
post-intervention (end of chemotherapy, duration of which varied
for each participant) between the intervention group 1 OnTrack
group (a supervised programme) (n = 71) compared to the usual
care control group (n = 66). However there were no significant
differences between the usual care control group and the inter-
vention 2 group Onco-Move (home-based programme) (n = 69).
Additionally, in the same study, the endurance timed test showed
significant effects favouring the intervention 1OnTrack group and
the intervention 2 Onco-Move group compared to the usual care
control group.
In the study by Haines 2010, the step test showed no significant
difference from baseline to post-intervention (six weeks) between
the intervention group (n = 32) and to the usual care control group
(n = 31). Data for the 12MWD (Mock 2005) were not reported.
Upper body strength
A total of five studies reported upper body strength assessed by
grip strength (Haines 2010; May 2017; VanWaart 2015), chest
press (Adamsen 2009), pull down (Adamsen 2009), elbowflexion (
VanWaart 2015), and 1-repetition max (1-RM) (Battaglini 2007).
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Meta-analyses were conducted for grip strength (Haines 2010;
May 2017; VanWaart 2015), findings of which showed that there
was probably no difference between the intervention group com-
pared to the usual care control group (MD 0.73 kg, 95% CI -0.86
to 2.32, I2 = 42%; 3 studies, 419 participants; moderate-certainty
evidence) (Analysis 1.3). Findings from a sensitivity analysis in-
cluding only studies with a low risk of bias (Haines 2010; May
2017) also indicated no difference (MD 0.21 kg, 95% CI -1.85
to 1.43, I2 = 0%, 2 studies).
Upper body strength data from individual studies
A narrative description of all other outcome results, reported be-
low, are presented in Table 1.
Adamsen 2009 reported significant improvements in the chest
press test and the pull-down test frombaseline to post-intervention
(six weeks) favouring the intervention group (n = 118) compared
to the usual care group (n = 117).
VanWaart 2015 reported a significant effect favouring the inter-
vention 1 OnTrack group (supervised programme) on the elbow
flexion test from baseline to post-intervention (duration of which
varied, dependent on each participants chemotherapy regimen) (n
= 71) compared to the usual care control group (n = 66), with no
significant effect between the intervention 2 Onco-Move group
(home-based programme) (n = 77) and the usual care control
group.
In the study by Battaglini 2007, data for 1-RMwere only reported
at pre-surgery and end of adjuvant cancer treatment time points.
No data were collected following surgery/before cancer treatment,
therefore, these data were not included in the review.
Lower body strength
A total of four studies reported lower body strength, assessed by leg
press (Adamsen 2009; Haines 2010), 30-second chair-stand test
(VanWaart 2015), knee extension (VanWaart 2015) and a cybex
dynamometer at angular velocities of 60°/s and 180°/s (right/left
knee extensor and flexor peak torque) (May 2017). Meta-analyses
were precluded for leg press due to substantial heterogeneity (85%)
which may be explained by the variation between both studies for
the duration of exercise intervention (six weeks versus six months),
different cancer types (several cancer groups versus breast) as well
as the wide variation in values reported (Adamsen 2009; Haines
2010).
Lower body strength data from individual studies
A narrative description of all other outcome results, reported be-
low, are presented in Table 1
For the leg press test, Adamsen 2009 reported a significant im-
provement from baseline to post-intervention (six weeks) favour-
ing the intervention group (n = 118) compared to the usual care
group (n = 117). Haines 2010 reported no significant differences
from baseline to post-intervention (six months) in the same test
between the intervention group (n = 30) and the usual care control
group (n = 29).
For the 30-second chair stand test, VanWaart 2015 reported no
significant between group effects. From baseline and post-inter-
vention (the duration of which varied, dependent on each par-
ticipant’s chemotherapy regimen), there were no significant dif-
ferences between the intervention 1 OnTrack group (supervised
programme) (n = 71) compared to the usual care control group (n
= 66) and, similarly, for the intervention 2 Onco-Move group (n
= 69) when compared to the usual care control group. In the same
study, the knee extension test showed a significant effect favour-
ing the intervention 1 OnTrack group compared to a reduction
in the usual care control group. However, no significant differ-
ences were reported between the intervention group 2Onco-Move
group (home-based programme) when compared to the usual care
control group.
In the study by May 2017, lower body muscle strength for flexion
and extension of both right and left legs were significantly higher
than the usual care control groups at 60o/s, but not for 180o/s
(P values were not provided). From baseline to post-intervention
(18 weeks), right knee extensor peak toque at 60o/s increased in
the intervention group (n = 63) compared to a reduction in the
usual care control group (n = 51). A similar change was reported
for right knee flexor peak torque at 60o/s; left knee extensor peak
torque at 60o/s; and left knee flexor peak torque at 60o/s. For
the right knee extensor peak torque at 180o/s, between baseline
to post-intervention, the intervention group showed an increase
compared to a reduction in the usual care control group whilst for
the right knee flexor peak torque at 180o/s, the intervention and
usual care control group had increased values. For the left knee
extensor peak torque at 180o/s, the intervention group increased
and the usual care control group decreased and for left knee flexor
peak torque at 180o /s, both the intervention and usual care control
group had increased values.
Physical activity
Physical activity was reported in five studies, all of which also used
different outcome measures: leisure time physical activity ques-
tionnaire (Adamsen 2009), international physical activity ques-
tionnaire (short-form) (Husebo 2014), physical activity for the
elderly (VanWaart 2015), physical activity questionnaire (Mock
2005) and physical activity (Short QUestionnaire to ASess Health
enhancing physical activity) (May 2017). This variation in out-
come measures precluded meta-analyses. Adamsen 2009 reported
pre-illness and baseline physical activity levels but no follow-up
data. Husebo 2014 reported no significant differences from base-
line to post-intervention (18 to 24 weeks) in the intervention
group (n = 29) 1333.66 (1367.67) metabolic equivalent of task
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(MET) minutes/week to 1621.12 (1734.42) compared to the
usual care control group (n = 31) 1138 (1148.81) to 1018.97
(1396.25), P =0.398.VanWaart 2015 reportedno significant find-
ings and raw data for physical activity in the elderly were not re-
ported. Mock 2005 reported non-significant findings for physical
activity with no raw data reported. However, on dividing the data
into high and low exercises, findings were significant. These data
were not reported in this review, as the subgroup analyses were
not clearly stated in the methods and this was judged as a possible
source of bias. Physical activity data in the study by May 2017
were not reported in the study and data were not provided.
Secondary outcomes
Safety
Eight of the 11 included studies reported safety (adverse events),
while the remaining studies did not (Battaglini 2007; Chandwani
2014; Reis 2013). Of these, seven reported that no significant
adverse events were related to the exercise programme. Adamsen
2009 reported that one participant with a brain tumour experi-
enced a grade three seizure after exercise training: this participant
was admitted to hospital, recovered within three hours, and was
discharged the same day. The participant was subsequently ex-
cluded from the intervention. The included studies showed low-
certainty evidence that exercise may be of benefit (8 studies, 638
participants).
Health-Related Quality of Life (HRQoL)
HRQoL was reported in seven studies measured using: European
Organisation for Research and Treatment of Cancer (EORTC
QLQ-C30) subscales (Adamsen 2009; Haines 2010; May 2017;
VanWaart 2015); EQ-5D (utility) (Haines 2010; May 2017),
EQ-5D (visual analogue scale (VAS)) (Haines 2010), Short Form
Health Survey (SF-36) (Adamsen 2009; Chandwani 2014; May
2017); World Health Organisation quality of life (WHOQOL)
(Hwang 2008) and Functional Assessment of Chronic Illness
Therapy-Fatigue (FACIT-F) (Reis 2013). In the study by Choi
2012, the type of HRQoL outcome measure was not reported.
Meta-analyses were conducted for EQ-5D (utility) and EORTC
subscales for: global health status, cognitive functioning, and so-
cial functioning. However, meta-analyses for other EORTC sub-
scales, such as role functioning, were not possible due to substan-
tial heterogeneity (76%) and similarly for emotional functioning
(82%), which may be due to the variation between the studies in
duration of exercise intervention (six weeks versus six months),
and also to the different cancer types (several cancer groups versus
breast), as well as the wide variation in values reported (Adamsen
2009; Haines 2010).
A meta-analysis was conducted using data from studies that re-
ported the EORTC global health state subscale (Adamsen 2009;
Haines 2010;May 2017). Findings showed that exercise may have
no difference on this subscale between the intervention group
compared to the usual care control group (MD 2.29, 95% CI -
1.06 to 5.65, I2 = 0%; 3 studies, 472 participants; low-certainty
evidence) (Analysis 1.4). Ameta-analysis was also conducted using
data from studies that reported the EORTC cognitive functioning
subscale (Adamsen 2009; Haines 2010; VanWaart 2015). Simi-
larly, there was probably no difference between the intervention
group compared to the usual care control group (MD 3.13, 95%
CI -0.55 to 6.80, I2 = 0%, 3 studies, 505 participants; moderate-
certainty evidence) (Analysis 1.5). The meta-analysis from studies
that reported social functioning (Adamsen 2009; Haines 2010;
VanWaart 2015) showed that there was probably no difference
between the intervention group compared to the usual care con-
trol group (MD 3.62, 95% CI -0.33 to 7.58, I2 = 0%, 3 studies.
505 participants; moderate-certainty evidence) (Analysis 1.6). A
meta-analysis was precluded for the EORTC physical functioning
subscale due to substantial heterogeneity (91%) (Adamsen 2009;
Haines 2010; VanWaart 2015). A narrative description from in-
dividual studies that reported EORTC results, reported here, are
presented below in Table 2. In the study by Adamsen 2009, from
baseline to post-intervention (six weeks), the physical functioning
subscale score was significantly greater in the intervention group
(n = 118) compared to the usual care control group (n = 117).
In contrast, Haines 2010 reported a reduction in the intervention
group (n = 33) and in the usual care control group (n = 32). The
study by VanWaart 2015 showed varied responses: intervention
group 1 demonstrated a reduction compared to an even greater
reduction in the usual care control group. Furthermore, they re-
ported a reduction in intervention group 2 which was significantly
different to the usual care control group. For the EORTC subscale
for role functioning, in the study by Adamsen 2009, there was no
significant difference in the role functioning subscale scores be-
tween the intervention group (n = 118) compared to the usual care
control group (n = 117). Similarly, in the study by Haines 2010,
from baseline to post-intervention (six months), there were no sig-
nificant differences between the intervention group (n = 33) and
usual care control group (n = 32). For the emotional functioning
subscale, in the study by Adamsen 2009, there were no significant
differences between the intervention group compared to the usual
care control group. Similarly, Haines 2010 reported no significant
difference between the intervention group compared to the usual
care control group.
A meta-analysis was conducted using data from studies that re-
ported EQ-5D (utility) (Haines 2010; May 2017). Findings
showed that there may be no difference between the intervention
group compared to the usual care control group (MD 0.01, 95%
CI -0.05 to 0.07, I2 = 9%, 2 studies, 263 participants; low-cer-
tainty evidence) (Analysis 1.7). Haines 2010 reported no signif-
icant differences from baseline to post-intervention (12 months)
for EQ-5D (VAS) between the intervention group (n = 33) com-
pared to the control group.
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Pooled data from studies that reported SF-36 (general health per-
ceptions subscale) (Adamsen 2009;Chandwani 2014) showed that
we are uncertain whether there are differences between the in-
tervention group compared to the usual care control group (MD
0.67, 95%CI -3.24 to 4.57, I2 = 33%, 2 studies, 317 participants;
very low-certainty evidence) (Analysis 1.8). A meta-analysis was
conducted using studies that reported the SF-36 subscale men-
tal health component (Adamsen 2009; Chandwani 2014). Find-
ings showed that we are uncertain whether there are differences
between the intervention group compared to the usual care con-
trol group (MD 2.58, 95% CI 0.16 to 5.01, I2 = 6%, 2 stud-
ies, 317 participants; very low-certainty evidence) (Analysis 1.9).
Additionally, pooled data from studies that reported the bodily
pain subscale (Adamsen 2009; Chandwani 2014) showed that we
are uncertain whether there are differences between the interven-
tion group compared to the usual care control group for this sub-
scale also (MD 0.06, 95% CI -3.03 to 3.15, I2 = 0%, 2 stud-
ies, 317 participants; very low-certainty evidence) (Analysis 1.10).
Due to substantial heterogeneity,meta-analyses were precluded for
the following subscales: physical component scale (71%), physi-
cal functioning (71%), and role physical (88%) (Adamsen 2009;
Chandwani 2014).
HRQoL data from individual studies
A narrative description of all other outcome results, reported be-
low, are presented in Table 2.
Adamsen 2009 reported that physical functioning reduced, with
a significant difference between the intervention group (n = 118)
compared to the usual care control group (n = 117). Chandwani
2014 reported no significant difference from baseline to post-in-
tervention between the intervention group (n = 39) compared to
the usual care control group (n = 43). Adamsen 2009 reported a
significant improvement in the physical component scale between
the intervention group (n = 118) compared to the usual care con-
trol group (n = 117). Chandwani 2014 reported no significant
difference between the intervention group and the usual care con-
trol group. For the role physical subscale, Adamsen 2009 reported
a significant improvement in the intervention group compared
to the usual care control group. Chandwani 2014 reported no
significant differences between the intervention group (n = 39)
compared to the usual care control group (n = 43). The study by
Adamsen 2009 reported other general well-being SF-36 subscales.
Between baseline and post-intervention (six weeks), there were
significant favourable effects reported for the intervention group
(n = 118) compared to the usual care control group (n = 117)
for the following subscales: (i) role physical; (ii) vitality; (iii) role
emotional; and (iv) mental health. For social functioning, there
were no statistical significant differences between the intervention
group compared to the usual care control group,
Hwang 2008 reported the subscales of the WHOWOL-BREF
score such as overall quality of life; overall health, physical, psy-
chological and social scores significantly increased from baseline to
post-intervention (five weeks) in the intervention group (n = 17)
compared to the usual care control group (n = 20). From baseline
to post-intervention, significant improvements were reported for
the intervention group compared to the usual care control group
for overall health; the physical subscale; the psychological subscale;
and for the social subscale. There was no significant differences
for the environmental subscale between the intervention group
compared to the usual care control group.
Reis 2013 reported several subscales of the FACIT-F question-
naire. From baseline to post-intervention (12 weeks), there were
no significant differences between the intervention group (n = 12)
and the usual care control group (n = 17) for physical well-being,
social/family well-being, emotional well-being, functional well-
being or FACT-G (no P values were reported).
The study by Choi 2012 reported significant differences between
the intervention group (n = 11) compared to the usual care control
group (n = 13) (however the tool used was not clearly reported).
Fatigue
Fatigue was reported in ten studies, measured using: EORTC
fatigue subscale (Adamsen 2009; VanWaart 2015); multidimen-
sional fatigue inventory (Haines 2010; May 2017; VanWaart
2015); brief fatigue inventory (BFI) (Chandwani 2014; Hwang
2008); Schwartz cancer fatigue scale (Choi 2012; Husebo 2014);
the Piper fatigue scale (PFS) (Mock 2005); and functional assess-
ment of chronic illness therapy-fatigue (FACIT-F) (Reis 2013).
Meta-analyses were conducted for the EORTC fatigue subscale
and multidimensional fatigue inventory. Meta-analyses were not
conducted for BFI as Hwang 2008 did not report data. Meta-anal-
yses were also precluded for the Schwartz cancer fatigue scale (Choi
2012; Husebo 2014), due to substantial heterogeneity (77%)
which may be explained due to both studies having contrasting
directions of effect.
A meta-analysis was conducted using data from studies that re-
ported the multidimensional fatigue inventory (Adamsen 2009;
May 2017; VanWaart 2015). Findings showed that exercise proba-
bly reduces fatigue (MD -1.05, 95% CI -1.83 to -0.28, I2 = 0%, 3
studies, 449 participants; moderate-certainty evidence) (Analysis
1.11). Pooled data from studies that reported the EORTC fatigue
subscale (Adamsen 2009; Haines 2010; VanWaart 2015) showed
that exercise probably reduces fatigue (MD -5.91, 95% CI -10.15
to -1.68, I2 = 0%, 3 studies, 506 participants; moderate-certainty
evidence) (Analysis 1.12).
Fatigue data from individual studies
A narrative description of all other outcome results, reported be-
low, are presented in Table 3.
For BFI, in the study by Hwang 2008, the authors reported that
“the mean BFI decreased in the intervention group (n = 17) and
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increased in the usual care control group (n = 20) between base-
line and post-intervention (five weeks) and there was a significant
difference in the change in BFI between groups favouring the in-
tervention group”. Data were only presented graphically, and raw
data were not available to be included in this review. For BFI,
Chandwani 2014 reported a significant effect favouring the inter-
vention group (n = 49) from baseline to post-intervention com-
pared to the usual care control group (n = 48).
For the Schwartz cancer fatigue scale, the study by Choi 2012
reported statistical differences favouring the intervention group
(n = 11) following a 8-week exercise programme compared to the
usual care control group (n = 13). The study by Husebo 2014
reported increases in fatigue scores using the same scale in both
the intervention group (n = 33) and the usual care control group
(n = 34), but P values were only reported for the whole sample.
For the FACIT-F score, the study byReis 2013 reported a statistical
significant improvement between baseline and post-intervention
(12 weeks) favouring the intervention group (n = 12) compared
to the usual care control group (n = 17).
For the Piper fatigue scale, in the study by Mock 2005, findings
were reported for high exercisers, low exercisers, and the entire
sample, however, no data were reported for the exercise interven-
tion or usual care control groups. Their findings showed that for
the PFS, there was a statistical significant difference favouring the
low exercisers mean (SD) 2.42 (2.63) to 4.28 (2.70) compared to
the high exercisers 2.44 (2.27) to 2.92 (2.00) (P < 0.01). For the
whole sample, from baseline to post-intervention, findings were
2.43 (2.46) to 3.64 (2.48) (P values were not presented).
Postoperative outcomes
No included studies reported postoperative outcomes.
Sensitivity analysis
Sensitivity analyses were conducted for grip strength and included
only studies of high quality (studies for which both allocation
concealment and incomplete outcome data were rated as low risk).
Findingswere consistentwith the overall summary effect estimates.
• Overall summary (MD 0.73 kg, 95% CI -0.86 to 2.31, I2 =
42%, 3 studies, 419 participants) (Haines 2010; VanWaart
2015; May 2017);
• Sensitivity analyses (MD 0.21 kg, -1.85 to 1.43, I2 = 0%, 2
studies, 213 participants) (Haines 2010; May 2017).
D I S C U S S I O N
Summary of main results
This is the first systematic review of reports of exercise training
interventions in people undergoing multimodal cancer treatment
including surgery. This review summarised 11 studies published
between 2005 and 2017, including 1067 participants (73% of
whom had breast cancer) and all studies were conducted in the ad-
juvant setting. Pooled analyses demonstrated that exercise training
in this context may have made little or no difference to physical
fitness. The included studies demonstrated that exercise training is
probably safe, makes little or no difference to HRQoL, but prob-
ably reduces fatigue. No studies reported postoperative outcomes
such as morbidity and survival. Our findings should be viewed
with caution, as overall we rated the certainty of evidence between
very low to moderate. Further higher quality trials are required to
confirm the efficacy of exercise interventions, particularly in the
neoadjuvant setting.
Overall completeness and applicability of
evidence
Findings from this review should be viewed with caution due to
the small sample sizes, the variety of cancer treatments, with many
different exercise interventions (supervised or home), andoutcome
measures.
An objective measure of physical fitness is the gold standard. Ob-
jective physical fitness levels of people with breast cancer, even be-
fore initiating adjuvant treatment, have been reported to be 17%
lower than healthy volunteer controls (Peel 2014); thus, the physi-
cal fitness of a 50-year old woman with breast cancer is comparable
to that of a sedentary 60-year old woman (Peel 2014). This decline
in physical fitness has been reported to be sustained for seven years
after treatment (Lakoski 2013). Cancer treatment (in the neoad-
juvant setting) has been shown to reduce whole body fitness, and
this reduction is related to poor surgical outcome (Jack 2014;West
2014). Furthermore, cancer treatment reduces objective physical
activity levels in people with colorectal cancer (Loughney 2017).
Two of the included studies reported objectively measured phys-
ical fitness (Adamsen 2009; May 2017). However, pooled analy-
sis demonstrated that there was probably no difference in phys-
ical fitness levels (VO2 max) following an exercise intervention
compared to usual care. Furthermore, no studies assessed phys-
ical activity levels objectively but assessed physical activity using
self-reportedmeasures. However, it has been recently documented
that people with cancer self-report their physical activity levels to
be nearly four-fold higher when compared to objective physical
activity monitoring data (Vassbakk-Brovold 2016).
Eight of the 10 included studies reported on safety (adverse events),
of which seven reported no adverse events related to treatment. In
this relatively new area of research, future exercise studies should
incorporate safety as an outcome measure.
HRQoL was reported in almost half of the included studies but
varied in the type of outcome measure used. It has been reported
that chemotherapy negatively effects HRQoL (Vrettos 2012).
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Pooled analysis demonstrated that exercise training probablymade
no difference to HRQoL (EORTC global health status subscale)
compared to usual care.
Fatigue was also a commonly reported outcome measure among
the included studies. Fatigue is one of the commonest side ef-
fects of cancer and cancer treatment, manifesting in the clinic as
weakness and exercise intolerance, which can affect quality of life
and physical activity. Pooled analysis demonstrated that exercise
training probably reduces fatigue (multidimensional fatigue in-
ventory).
We do not know whether an exercise intervention improves post-
operative outcomes, such as survival, as no study reported these.
Quality of the evidence
The overall quality (certainty) of the evidence for each of the im-
portant outcomes in the review are reported in the Summary of
findings for the main comparison.
The aim of this review was to identify studies that included an ex-
ercise intervention for people with cancer undergoing multimodal
treatment. However, no studies were identified in the neoadjuvant
setting. Due to the nature of the intervention, it was not possible
to blind the participants or personnel delivering the intervention.
The risk of detection bias was high or unclear in some cases whilst
most other domains were rated as low risk. The certainty of the
evidence was graded between moderate to very low. The included
studies varied greatly in the type of cancer treatments (radiation,
chemotherapy, hormonal therapy, and other systemic treatment),
the duration of the exercise training (between five weeks to 12
months, and, in some cases, the precise duration was unclear, the
setting (supervised or home-based), the frequency (two to three
times per week), the intensity (varied in method of prescription),
time (25 min to 90 min) and type (home-based exercises or ma-
chine-based exercise) of the intervention. Time points of assess-
ments and outcome measures also varied considerably. Only three
studies had roughly the same duration of exercise intervention (+/-
one week), but in these, the outcome measures differed (Adamsen
2009; Chandwani 2014; Hwang 2008).
Potential biases in the review process
This systematic review included search strategies for the Cochrane
Central Register of Controlled Trials (CENTRAL), MEDLINE,
Embase and SPORTDiscus, which were formulated by the
Cochrane Gynaecological, Neuro-oncology and Orphan Cancers
Group. The search strategies were first conducted in January 2017,
August 2017, and October 2018. Two authors independently
screened candidate articles using predefined search terms, and un-
dertook data extraction, and risk of bias judgment independently.
Although we emailed all authors for missing data, some did not re-
ply. Therefore, exclusion of these results may be a potential source
of bias. The sample population consisted largely of breast can-
cer patients (73%), therefore findings may not be generalisable to
other cancer types. Conclusions drawn from this review are lim-
ited by the low number of included studies, as well as the lack of
eligible studies in the neoadjuvant setting.
Agreements and disagreements with other
studies or reviews
Consistent with findings presented in a recent review Jones 2013,
we found that the majority of work conducted in the adjuvant set-
ting includes people with breast cancer. This review is in agreement
that there are few studies in this area, limiting our understanding
of the most effective exercise training programme (Crandall 2014;
Granger 2011; Jones 2007; West 2011).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The included studies demonstrated low-certainty evidence that ex-
ercise training may make little or no difference to physical fitness.
The included studies also showed that it is probably safe to ex-
ercise. Moderate-certainty evidence suggests that exercise training
probably makes little or no difference toHRQoL, but that exercise
probably reduces fatigue. The current evidence is based on a small
number of studies which greatly varied by cancer treatment, ex-
ercise intervention, and outcomes. The characteristics and setting
(supervised or home) of an exercise programme are not known,
therefore, more research is required to inform implications for
practice.
Implications for research
This reviewmakes it clear that amore focused approach is required
in future studies to include similar outcome measures and simi-
lar duration of exercise interventions for better inter-study com-
parisons. Furthermore, blinding of outcome assessors is required.
Additionally, most of this work included people with breast can-
cer (73%), therefore, more research is required with other can-
cer patient groups. Future work should include those undergoing
more major surgery, such as bowel surgery. For example, it has
been shown that, in people with colorectal and oesophageal can-
cer, neoadjuvant cancer treatments significantly reduce physical
fitness before surgery and this reduction is linked to poor postop-
erative outcomes (Jack 2014; West 2014). Although it is encour-
aging that five of the ongoing studies identified are investigating
exercise interventions in the neoadjuvant setting, there is an ur-
gent requirement for adequately powered RCTs and to investigate
effects on postoperative outcomes. A cancer diagnosis may lead
individuals to make positive changes to their health behaviours,
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a concept sometimes called the ’teachable moment’. Future work
should investigate the effectiveness of exercise training, initiated
at cancer diagnosis, throughout the entire cancer care journey.
Better understanding of the optimal training duration, pattern,
intensity, and composition of such interventions will be needed
to maximise efficacy. The included studies in this review demon-
strated that the countries currently leading this area of research are
the USA with four studies, Korea and the Netherlands with two
studies each, and Norway, Australia, and Denmark with one study
each. Perhaps international collaboration to advance generalisable
research in this area is required to answer these important research
questions. Furthermore, addressing the substantial heterogeneity
in both interventions and outcome measurements should also be
a priority for researchers. Efforts to harmonise or standardise re-
porting of characteristics of exercise interventions and outcome
measures to quantify physical exercise outcomes within such stud-
ies would be of value in improving opportunities to compare, con-
trast, and combine such data in order to better understand the
impact of interventions for people with cancer (Myles 2016). We
suggest answering the following specified research questions in fu-
ture studies:
• What is the optimal time to initiate an exercise programme
and what kind of programme is the most effective in improving
clinically important outcome measures?
• What is the optimal prescribable dose of exercise and in
what format will this most benefit cancer patients?
• Does combining aerobic and resistance exercise programmes
improve the response and provide greater outcome benefits?
• Is a home-based exercise training intervention as effective as
supervised training in-hospital intervention? Although home
programmes may be cheaper and more convenient for the
patient, to date, the evidence suggests that they may not be as
effective with low adherence rates. Also, what are the social
benefits of exercising in groups compared to home programmes?
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adamsen 2009
Methods Study design: two-arm randomised controlled trial
Methods of participant recruitment: Quote: “The patients were approached and en-
rolled by research nurses or by physicians and nurses from eight treatment departments”
Aim of study:Quote: “To investigate the effect of a six week supervised structured group
intervention comprising high intensity physical training and low intensity training in an
intervention group compared with a control group”
Start date of study:March 2004
End date of study: March 2007
Total study duration: 3 years
Country: Denmark
Sample size: 270
Duration of follow-up: 6 weeks
Study funding source:Quote: ”This research was supported by grants from The Lund-
beck Foundation, The Novo Nordic Foundation, The Egmont Foundation, The Dan-
ish Cancer Society, The Svend Andersen Foundation, The Aase and Ejnar Danielsen
Foundation, The Beckett Foundation, The Wedell-Wedellsborg Foundation, The Hede
Nielsen Family Foundation, The Gangsted Foundation, Copenhagen University Hos-
pital. The authors’ work was independent from the funders“
Declaration of conflict of interest: none declared
Participants Included criteria: Quote: “Participants were eligible if they had a diagnosis of cancer,
had received at least one cycle of chemotherapy for advanced disease or as adjuvant
treatment, had a WHO performance status of 0 or 1, and were aged 18-65 years”
Excluded criteria: Quote: “Exclusion criteria were brain or bone metastases, thrombo-
cytopenia (50×109/L), myocardial infarction within the past three months, or uncon-
trolled hypertension (diastolic pressure > 95 mm Hg)”
Total no randomised: 269
No. intervention group: 135
No. control group: 134
Baseline imbalances: Quote: “the control and intervention groups were matched at
baseline for demographic and medical characteristics”
Age (years):
Intervention: 47.2 ± 10.7;
Control: 47.2 ± 10.6
Gender: 73 male and 196 female
Race/ethnicity: not reported
Cancer type: 21 different cancer diagnoses: 17 with solid tumours and 4 with malignant
haematological diseases. Forty-eight per cent had evidence of disease
Cancer treatment: Quote: ”59 different chemotherapy regimens. The most frequent
chemotherapy regimen included cyclophosphamide, epirubicin, and 5-fluorouracil and
was administered to 49 patients in each group. Also frequent were 5-fluorouracil based
regimens in patients with colorectal cancer (12 in the control group and 14 in the
intervention group) and platinum based regimens in women with ovarian cancer (10
v 15) and in men with testicular cancer (eight v six). All other regimens were given to
29Exercise interventions for people undergoing multimodal cancer treatment that includes surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Adamsen 2009 (Continued)
fewer than five patients and regimens were balanced between groups”
Attrition rate: 12.7%
No. intervention group assessed at follow-up time point: 6 weeks (118);
No. control group assessed at follow-up time point: 6 weeks (117)
Reasons for withdrawal:
No. intervention group at week 6 (n = 17): never started (2), infections (7), bone marrow
suppression (4), excluded (1), other health problems (3);
No. control group at week 6 (n = 17): non-contactable (3), absent from test (8), infections
(2), bone marrow suppression (4)
Interventions Intervention characteristics
Intervention
• Setting: hospital-based
• Group/non-group based: group-based
• Components of programme: aerobic, strength, balance and coordination, relaxation
• Frequency: 3 sessions/week x 6 weeks
• Intensity: high and low intensity sessions
High intensity: aerobic: 85%-95%maximum heart rate. Estimated intensity of 15METs
(3.75 MET hours per training session)
Strength: 70%-100% 1RM, estimated intensity of 5.5METs (4MET hours per training
session)
Low intensity: (relaxation training and massage), estimated to have an intensity of 1
MET (total of 3 MET hours per week), while body awareness and restorative training
were estimated to have an intensity of 2.5 METs (3.25 MET hours per week)
• Time:
High intensity: 90 mins
Low intensity: 30 mins
• Type:
High intensity: aerobic: cycle ergometer; strength: 6 machines: leg press, chest press,
pull-down, abdominal crunch, lower back, knee extension
Low intensity: relaxation, body awareness and restorative training, and massage
• Monitoring during exercise: heart rate (wireless heart rate transmitter). Quote:
“The inclusion and exclusion criteria, the daily screening procedures, the presence of
the clinical nurse specialist during training, and training phygmomanometer ensured
the required level of safety”.
• Support source: Quote: “the participants could contact the project team directly;
information was accessible on posters and pamphlets in the hospitals inpatient and
outpatient departments”.
• Adherence: 70.8%
• Adverse events: Quote: “Five participants with breast cancer had lymphoedema at
baseline; none experienced exacerbations during the intervention. One participant
with a brain tumour experienced a grade 3 seizure after cardiovascular training. This
participant was admitted to the hospital, recovered within 3 hours, and was discharged
the same day. The participant was subsequently excluded from the intervention”.
Outcomes Aerobic fitness (VO2 max)
• Outcome type: continuous
• Unit of measure: L/min
• Direction: higher is better
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Adamsen 2009 (Continued)
Upper body muscle strength (chest press)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Upper body muscle strength (pull-down)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Lower body muscle strength (leg press)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Physical activity (leisure time physical activity questionnaire)
• Outcome type: continuous
• Direction: higher is better
HRQoL (EORTC QLQ-C30 subscales)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
HRQoL (Medical Outcome Study (MOS) SF-36 subscales)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
Fatigue (EORTC QLQ-C30)
• Outcome type: continuous
• Scale: 0-100
• Direction: lower is better
Identification Setting: Rigshospitalet and Herlev Hospital (Copenhagen University Hospitals)
Authors name: Adamsen L
Institution: University Hospitals Centre for Nursing and Care Research, Copenhagen
University Hospital
Email: la@ucsf.dk
Address:University Hospitals Centre for Nursing and Care Research, Copenhagen Uni-
versity Hospital, DK-2100 Copenhagen, Denmark
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment: Quote: “Randomi-
sation was done by computer (Clinical
Internet Trial Management System: CIT-
MAS). The allocation sequence was exe-
cuted by the clinical research unit and con-
cealed from the project team”
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Adamsen 2009 (Continued)
Allocation concealment (selection bias) Low risk Judgement comment: Quote: “The alloca-
tion sequence was executed by the clini-
cal research unit and concealed from the
project team”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: Quote: “The data
were collected by a physiotherapist and
a trained nurse specialist, who also con-
ducted the daily training sessions. Data
were anonymised by use of an identifica-
tion code; administrative data were kept in
a separate database. Blinding the partici-
pants to group assignment was not possi-
ble”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement comment: Quote: “Outcome
measures were keyed in and analysed by
research assistants who were not involved
with the participants”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: consented: 269,
completed: 235. Consort provided (attri-
tion 12.7%)
Selective reporting (reporting bias) Low risk Judgement comment: All outcomes listed
in methods were reported sequentially in
the results section
Other bias High risk Judgement comment: Various cancer treat-
ments were included and 52% of partici-
pants did not have cancer which makes re-
sults difficult to interpret
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Battaglini 2007
Methods Study design: two-arm randomised controlled trial
Methods of participant recruitment: Quote: “All the subjects were recruited from the
northern Colorado region through oncology practices between January 2001 and April
2003. Patients were screened for participation based upon a physician’s review of the
patient’s medical history and a physical examination”
Aim of study: Quote: “The main purpose of this study was to assess the effects of an
individualized exercise intervention emphasizing resistance training, on changes in body
composition and muscle strength in breast cancer patients during treatment”
Start date of study: January 2001
End date of study: April 2003
Total study duration: 27 months
Country: United States
Sample size: 20
Duration of follow-up: 15 weeks
Study funding source:Quote: “University of Northern Colorado, Sponsored Programs
and Academic Research Center”
Declaration of conflict of interest: none declared
Participants Included criteria: Quote: “recently been diagnosed with breast cancer, and designated
for surgery and chemotherapy treatment“
Excluded criteria: Quote: “The criteria for non-participation in the study included the
presence of cardiovascular disease; acute or chronic respiratory disease; acute or chronic
bone, joint or muscle abnormalities (unless these diseases would not compromise the
patient’s ability to participate in the exercise rehabilitation program); metastatic disease;
and immune deficiency”
Baseline imbalances: not reported
No. recruited: 20
Total no. intervention group: 10
Total no. control group: 10
Age (years):
Intervention: 57.5 ± 23
Control: 56.6 ± 16
Gender: female
Race/ethnicity: not reported
Cancer type: breast cancer
Cancer treatment: adjuvant chemotherapy
Attrition rate: 100%
No. intervention group assessed at follow-up time point: 15 weeks (10);
No. control group assessed at follow-up time point: 15 weeks (10)
Reasons for withdrawal: N/A
Interventions Intervention characteristics
• Setting: rehabilitation centre
• Group/non-group based: not reported
• Frequency: 2 sessions/week x 15 weeks
• Intensity: Aerobic: not clear. Quote: “Each of the individualized exercise
prescriptions was based on the results from the fitness assessment administered at the
beginning of the study”. Resistance: not clear. Quote: “For the resistance exercise
portion of the exercise protocol, the intensities of the exercises were determined
according to the results obtained in the first fitness assessment”.
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Battaglini 2007 (Continued)
• Time: warm-up: approximately 6-12 minutes, whole-body stretching sessions (5-
10 minutes), resistance training (15-30 minutes), cool-down: approximately 8 minutes.
• Type: aerobic: treadmill/cycle ergometer/elliptical equipment; resistance training:
Quote: “eight to twelve different types of resistance exercises emphasizing all the major
muscle groups were utilized. All the resistance exercises were performed using weight
training machines, free weights (hand dumbbells), elastic bands, and/or therapeutic
balls. The resistance exercises that were assigned to the exercise group included: lateral
and frontal raises, horizontal chest press, lateral pull down, alternating biceps curls with
dumbbells, triceps extension, leg press, leg extension, leg curl, standing calf raises and
three different types of abdominal exercises (forward crunches, oblique crunches, and
lower abdominal crunches)”.
• Monitoring during exercise: Heart rate. Quote: “Each patient wore an A3 Polar
heart rate monitor (Lake Success, New York) to determine resting heart rate and to
monitor heart rate responses during cardiovascular assessments, as well as for
controlling intensities during exercise sessions”.
• Support source: not reported (may not be applicable due to the nature of the
supervised programme)
• Adherence: 100%
• Adverse events: safety was not reported
Outcomes Aerobic fitness (VO2 max)
• Outcome type: continuous
• Unit of measure: L/min
• Direction: higher is better
Upper body muscle strength (1 repetition maximum)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Identification Setting: Campus Recreation Centre and Rocky Mountain Cancer Rehabilitation Insti-
tute of the University of Northern Colorado, and the North Colorado Medical Centre
(Northern Colorado region)
Authors name: Battaglio C
Institution:RockyMountainCancerRehabilitation Institute of theUniversity ofNorth-
ern Colorado, in Greeley, Colorado
Email: claudio@email.unc.edu
Address: Department of Exercise and Sport Science, University of North Carolina at
Chapel Hill, Chapel Hill, NC 27599, USA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment:: “The randomiza-
tion procedure involved the drawing of
numbers by the patients, which ranged
from 1 to 20. Subjects who drew even
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numbers were placed into the experimental
group while subjects who drew odd num-
bers were placed into the control group”
Allocation concealment (selection bias) Unclear risk Judgement comment: not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible due to
nature on intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Judgement comment: not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment:: “the adherence rate
among all the subjects was 100%”
Selective reporting (reporting bias) High risk Judgement comment: Data for cardiovas-
cular endurance were not reported
Other bias High risk Judgement comment: Time points of as-
sessments included pre-surgery and post
adjuvant cancer treatment only (start of ad-
juvant cancer treatment was not reported)
therefore interpretation of findings are dif-
ficult
Chandwani 2014
Methods Study design: three-arm randomised controlled trial (only 1 intervention and control
arm were reported in this systematic review)
Methods of participant recruitment:Quote: “Eligible patients were identified through
an institutional database or by referring physicians and were approached at their simu-
lation appointment”
Aim of study:Quote: “To investigate the effects of yoga on quality of life in people with
breast cancer”
Start date of study: Sept 2006
End date of study: August 2009
Total study duration: 35 months
Country: United States
Sample size: 150
Duration of follow-up: 6 weeks
Study funding source: not reported
Declaration of conflict of interest: none declared
Participants Included criteria: Quote: “Inclusion criteria were 18 years old or older; ability to read,
write, and speak English; and scheduled to undergo daily adjuvant XRT for 6 weeks at
MD Anderson Cancer Center”
Excluded criteria: Quote: “Patients with lymphedema; metastatic bone disease; deep
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vein thrombosis; documented diagnosis of a formal thought disorder (e.g. schizophrenia)
; extreme mobility problems; or who had practiced YG in the year before diagnosis were
excluded”
Baseline imbalances:Quote: “All groups were similar in baseline demographic, medical,
self-report measures (except for SF-36 GH), and cortisol slopes”
Total no. randomised: 178
No. intervention group: 53
No. control group: 54
Age (years):
Intervention group: 52.4 ± 1.4
Control group: 52.1 ± 1.3
Gender: female
Cancer type: breast cancer stage 0-III
Cancer treatment: adjuvant radiotherapy
Race/ethnicity:
Intervention group 1: black/African American (9); white (32); Latino/Hispanic/Mexican
(4); Asian/Pacific Islander (2); other (0);
Control group: black/African American (7); white (37); Latino/Hispanic/Mexican (5);
Asian/Pacific Islander (1); other (2)
Attrition rate: 30.9%
No. intervention group assessed at follow-up time point: post-treatment (39)
No. control group assessed at follow-up time point: post-treatment (43)
Reasons for withdrawal: 13 dropped out before and 15 after randomisation in Inter-
vention groups (reasons not provided)
Interventions Intervention characteristics
Intervention
• Setting: hospital-based (large conference style rooms near the radiation treatment)
• Group/non-group based: one-to-one (given before or after radiotherapy to
accommodate participants’ schedules)
• Frequency: 3 sessions/week
• Intensity: light intensity (restorative yoga)
• Time: 60 mins
• Type: (1) preparatory warm-up synchronized with breathing; (2) selected postures,
or asana (forward-, backward-, and side-bending in sitting and standing position, cobra
posture, crocodile, and half-shoulder-stand with support); (3) deep relaxation (supine
posture); (4) alternate-nostril breathing, or pranayama; and (5) meditation
• Monitoring during exercise: not reported
• Support source: not reported
• Adherence: 87%
• Adverse events: not reported
Outcomes HRQoL (SF-36)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
Fatigue (Brief fatigue inventory (BFI)
• Outcome type: continuous
• Scale: 0-10
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• Direction: lower is better
Identification Setting: MD Anderson Cancer Centre.
Authors name: Lorenzo Cohen
Institution: Integrative Medicine Program, The University of Texas MD Anderson
Cancer Center, Department of Integrative Medicine
Email: lcohen@mdanderson.org
Address: Integrative Medicine Program, The University of Texas MD Anderson Cancer
Center, Department of Integrative Medicine, 1515 Holcombe Blvd,Unit 460, Houston,
TX 77030
Notes Note: Stretching group was not included into this review as it did not meet the inclusion
criteria as an exercise intervention
Quote: “Participants were given a gift certificate ($20 value) after each assessment com-
pletion”
Some data were taken from a separate publication linked to this study: reference: Ratcliff
CG, Milbury K, Chandwani KD, Chaoul A, Perkins G, Nagarathna et al. Examining
mediators and moderators of yoga for women with breast cancer undergoing radiother-
apy. Research Articles, 2016: 1-13
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement comment: unclear. Quote:
“Participants were then randomly assigned
to one of three groups: 1) YG; 2) ST; orWL
control by using a form of adaptive ran-
domization,according to age, stage of dis-
ease, time since diagnosis, type of surgery,
and chemotherapy (neoadjuvant or adju-
vant)”
Allocation concealment (selection bias) Unclear risk Judgement comment: not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible due to
the nature of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Judgement comment: author email cor-
respondence: “for questionnaires, patients
would sometimes reveal their group”
Incomplete outcome data (attrition bias)
All outcomes
High risk Judgement comment: consented 191; com-
pleted 132. Consort provided (attrition 30.
9%)
Selective reporting (reporting bias) Low risk Judgement comment: all prespecified out-
comes were reported accordingly
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Other bias Low risk Judgement comment: none identified
Choi 2012
Methods Study design: two-arm randomised controlled trial
Methods of recruitment of participants: not reported in translated script
Aim of study: to evaluate the effect of a home-based exercise program for randomly-
assigned stomach cancer patients receiving oral chemotherapy after surgery
Start date of study: September 2007
End date of study: June 2008
Total study duration: 10 months
Country: Korea
Sample size: 28
Duration of follow-up: 8 weeks
Study funding source: not reported
Declaration of conflict of interest: not reported
Participants Included criteria:Quote: “1. Patients diagnosed with gastric cancer (Ib, II, III) receiving
oral chemotherapy following surgery; 2. ECOG (Eastern Cooperative Oncology Group)
Performance score ranging from 0-23.The following detected through complete blood
count (CBC): haemoglobin count of more than 10g/dL, leukocyte count more than
2000/mm; 3 (Absolute Neutrophil Count (ANC) > 1000), platelet count of more than
100,000m3 ; 4. Patients aged over 20 years capable of filling out a questionnaire; 5.
Patients capable of understanding the purpose of the study and able to give written
consent”
Excluded criteria: Quote: “Patients who do not consume drugs that affect the immune
system; Patients who do not have acute or chronic pain that could interfere with physical
activity”
Baseline imbalances: not reported
Total no. randomised: 28
No. intervention group: 14
No. control group: 14
Age (years):
Intervention: < 50 (n = 3); 51-60 (n = 4); > 61 (n = 4)
Control: < 50 (n = 0); 51-60 (n = 4); > 61 (n = 9)
Gender: male and female
Intervention: male (n = 5); women (n = 6)
Control: male (n = 9); women (n = 4)
Race/ethnicity: not reported
Cancer type: stomach cancer
Cancer treatment: oral chemotherapy
Attrition rate: 14.8%
Intervention: 11/14
Control: 12/14
Reason for withdrawal:
Intervention (n = 3): rejected the treatment (1), rejected the intervention (1), cancer
metastasis (1)
Control (n = 1) (cancer metastasis)
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Interventions Intervention characteristics
• Setting: home-based
• Group/non group-based: non-group based
• Components of programme: aerobic
• Frequency: more than 3 times/week x 8 weeks
• Intensity: moderate intensity
• Time: 60 minutes: 5 minutes of warming up, 45 minutes of exercise, and 10
minutes of cool down
• Type: walking
• Monitoring during exercise: self-monitoring diary and pedometer. Patients were
provided a pedometer to use for the self-monitored diary records and were instructed
to wear it on one’s waistband while exercising.
• Source of support: Quote: “A telephone conversation was conducted once a week
for approximately 5 to 10 minutes for 8 weeks. A short message service (SMS) message
for exercise reinforcement was sent once every week to each patients’ cell phone for a
total of 8 weeks, which consisted of a text message of less than 40 characters.
• Adherence: Quote: ”3.8 exercises per week, the average number of steps measured
by the pedometer was 6050.“
• Adverse events: not reported
Outcomes Health related quality of life (tool not described)
• Outcome type: continuous
• Scale: 14-70
• Direction: higher is better
Fatigue (Schwarts Cancer Fatigue Scale (SCFS-6)
• Outcome type: continuous
• Scale: 6-30
• Direction: lower is better
Identification Setting: Medical Centre, Seoul City
Comments: this article was translated by Heather Swan
Authors name: Jin Yi Choi
Institution: College of Nursing Science, Kyung Hee University, Seoul, Korea
Email: hyunsuk@khu.ac.kr
Address: College of Nursing Science, Kyung Hee University, Seoul, Korea
Notes Quote: ”The exercise program was developed based on the research of Winningham,
Glass andMacVicar (1990) and thewalking informationof theKoreaAthletic Promotion
Association (2007). The program was modified and supplemented according to the
advice of exercise experts. In order to improve the validity of the home exercise programs
developed by the researchers, the opinions of three cancer rehabilitation and exercise
experts were obtained and confirmed following each exercise, patients were instructed
to record the number of steps, exercise duration and how they felt in the self-monitored
diary, in addition to the date and time and self-reported fatigue. The outpatient clinic
provided a home exercise program booklet prepared for participants in the experimental
group. Participants were also individually educated for 20 to 30 minutes“
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Judgement comment: Quote: ”Due to the
ease of data collection, participants were se-
lected on the basis of accessibility through
convenient sampling“
Allocation concealment (selection bias) High risk Judgement comment:Quote: Patients were
randomly assigned to the experiment or
control group by the researcher picking up
one of two folded papers with either the
number ‘1’ or ‘2’ printed on it. As a result,
the number 1 was assigned to the experi-
mental group, and the number 2 was as-
signed to the control group. The number
of subjects was not the same for the pur-
poses of this study and so it was not possible
to calculate the magnitude of effects. Ad-
ditionally, due to the nature of the cancer,
there is a limit to the accessibility, unlike
with more common illnesses”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible due to
the nature of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Judgement comment: not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: consented 27; com-
pleted 23 (attrition (14.8%)
Judgement comment: There was no con-
sort provided but data were provided.
Quote: “During the 10-month data collec-
tion period, 3 of the 14 participants in the
experiment groupwere excluded (1 rejected
the treatment, 1 rejected the intervention,
and 1 had cancer metastasis) and 1 of the
participants from the control group was ex-
cluded (cancer metastasis). Ultimately, the
experimental group had 11 participants,
and the control groups had 13”
Selective reporting (reporting bias) Low risk Judgement comment: All outcome mea-
sures were clearly described and reported
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Other bias High risk Judgement comment: The measure of
HRQoL reportedwas not clearly stated. Al-
though reference was made about the mea-
sure within the study to two other studies,
the references are an unpublished doctoral
dissertation and a master’s thesis
Haines 2010
Methods Study design: two-arm randomised controlled trial
Methods of recruitment of participants:Quote: “Potential participants were identified
at their 2-week post surgery Breast Clinic appointments or when booked in for radiation
therapy ‘planning’“
Aim of study: Quote: “aimed to evaluate the efficacy and economic efficiency of a
multimedia, multimodal exercise program for the enhancement of health related quality
of life amongst womenwith breast cancer undergoing adjuvant therapy following surgery
for breast cancer”
Start date of study:May 2006
End date of study: September 2007
Total study duration: 16 months
Country: Australia
Sample size: 89
Duation of follow-up: 12 months
Study funding source: Quote: ”This study was funded by a project grant from the
Princess Alexandra Hospital Cancer Collaborative Group. Associate Professor Terry P
Haines is supported by a National Health and Medical“
Declaration of conflict of interest: none declared
Participants Included criteria:Quote: “Participants in this study were women with newly diagnosed
breast cancer undergoing adjuvant therapy (radiation therapy, chemotherapy and hor-
monal therapy) following surgery”
Excluded criteria: Quote: “Exclusion criteria were severe cardiac disease, uncontrolled
hypertension or orthopaedic injury precluding participation in an exercise program”
Baseline imbalances: yes, as presented in baseline characteristics table
Total no. randomised: 89
No. intervention group: 46
No. control group: 43
Age (years):
Intervention group: 55.9 ± 10.5
Control group: 54.2 ± 11.5
Gender: female
Race/ethnicity: not reported
Cancer type: breast cancer (staging not provided)
Cancer treatment: adjuvant treatment (prescription not provided)
Attrition rate: 18%
No. intervention group assessed at follow-up time point: 12 months (37)
No. control group assessed at follow-up time point: 12 months (36)
Reasons for withdrawal: not reported
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Interventions Intervention characteristics
• Setting: home-based
• Group/non-group based: alone
• Duration of programme: 12 months
• Frequency: Number of sessions per week were not described.
• Intensity: not clear. Quote: “Strategies of progression were recommended to make
exercises harder every 2-4 weeks particularly if muscles were not feeling tired after
completing the second set of exercises (for strength exercises), If the minimum number
of repetitions within a set could not be completed, then the participants were
recommended to try an easier version of that exercise. Participants were recommended
to complete one set of each exercise, then complete a second set so that specific muscle
groups could rest between sets”.
• Time: Aerobic (20 min); balance/strength/mobility (36 min) varied between: 5-15
repetitions x 2/3 sets.
• Type: Aerobic (walking) and balance/strength/mobility (lunges, bicep curls, wall
push-ups, standing hip abduction, seated rows with resistance tubing, sit to stand with
emphasis on eccentric control of stand to sit, overhead press, heel raises, shoulder
mobility/rolling orange in large circles on kitchen tables, four quadrant step test)
• Monitoring during exercise: not reported
• Support source: phone call from member of research team
• Adherence: Adherence was reported as number of sessions. At 3 months: median
(IQR) sessions: strength and balance 32 (19, 39) and endurance 22 (16.5, 34); at 6
months median (IQR) strength/balance 12 (6.25, 37) and endurance 13 (2.75, 27.25).
• Adverse events: Quote: “There were nine participants who reported
musculoskeletal pain in their adverse event logs (three control, six intervention: odds
ratio (95% CI): 2.39 (0.58, 89.92), P = 0.23), three of which reported pain whilst
performing exercises as a part of the intervention program and one as a part of the
control program. Participants ceased performing the provoking exercise in each case.
There were eight fallers (one fall each) during the study period (five control, three
intervention: odds ratio (95% CI): 0.58 (0.14, 2.42), P = 0.48), one of which resulted
from an intervention group participant tripping on a tree stump whilst undertaking the
walking program”.
Usual care control group
• Setting: home-based
• Supervision: unsupervised
• Group/non-group based: alone
• Components of programme: flexibility and relaxation
• Frequency: number of sessions in 12-month period not clear
• Intensity: not clear
• Time: flexibility: 30s x 3 repetitions, relaxation: 10 min
• Type: flexibility: static stretching, quadriceps, gastrocnemius, biceps, triceps,
trapezius, pectoralis major; relaxation: supine relaxation program following the
Feldenkrais method
• Monitoring during exercise: not reported
• Support source: phone call from member of research team
• Adherence: Adherence was reported as number of sessions. At 3-months: median
(IQR) sessions: flexibility 30.5 (18.75, 36) and relaxation 28.5 (13.25, 36). At 6-
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months median (IQR) flexibility 22.5 (7, 36.5) and relaxation 18 (1.5, 33.5).
• Adverse events: There were nine participants who reported musculoskeletal pain in
their adverse event logs (three control, six intervention: odds ratio (95% CI): 2.39 (0.
58, 89.92), P = 0.23), three of which reported pain whilst performing.
Outcomes Aerobic fitness (step test - steps in 15 secs)
• Outcome type: continuous
• Direction: higher is better
Aerobic fitness (6-minute walk test)
• Outcome type: continuous
• Unit of measure: metres
• Direction: higher is better
Upper body muscle strength (grip strength)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Upper body muscle strength (leg press)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
HRQoL (EQ-5D visual analogue scale (VAS)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
HRQoL (EQ-5D Utility)
• Outcome type: continuous
• Scale: 0.59-1
• Direction: higher is better
HRQoL (EORTC subscales)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
Fatigue (multidimensional fatigue inventory (MFI)
• Outcome type: continuous
• Scale: 0-20
• Direction: lower is better
Fatigue (EORTC)
• Outcome type: continuous
• Scale: 0-100
• Direction: lower is better
Identification Setting: Quote: “The Princess Alexandra Hospital: provides cancer services to residents
on the south side of Brisbane extending down to the Gold Coast region in Queensland,
Australia”
Authors name: T. P. Haines
Institution: Allied Health Clinical Research Unit, Kingston Centre
Email: terrence.haines@med.monash.edu.au
Address:AlliedHealthClinical ResearchUnit, Kingston Centre,SouthernHealth, Chel-
tenham, Victoria 3192, Australia
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Notes Interventional notes as follows:
Quote: ”Participants allocated to the home-based strength, balance, shoulder mobility
and cardiovascular endurance program received amultimedia instructional package along
with equipment to facilitate the completion of the program. Participants were provided
with pedometers and water weights (3 kg capacity) 6 pieces of rubber band (2 pieces x
3 resistance grades) and 2 re-usable shopping bags (one of which acted as the program
materials bag”
Quote: “The DVD included general safety precautions related to exercise, health advice
related to the post-surgical period, a description of how to use the materials that had
been provided with the program, a description of how to perform and progress each
exercise in the program and a description of how to record data in log books related to
adherence, adverse events and use of health care resources”
Usual care control note as follows:
Quote: “An active (sham intervention) control condition was employed consisting of
flexibility and relaxation activities. Previous studies have highlighted problems of
increased activity levels amongst women with breast cancer allocated to ‘usual activity’
control groups. This potential bias was addressed by providing patients in the control
groupwithwhat looked like an exercise programwith an equivalent amount of supporting
material. The video material was of similar content to that in the intervention program
(though the actual exercises described differed). There was no progression of activities
performed in this condition”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment:Quote: “Participants
were randomised to intervention or control
groups using a computer-generated ran-
domization sequence that was entered into
numbered, opaque, sealed envelopes by a
study investigator (TH)”
Allocation concealment (selection bias) Low risk Judgement comment:Quote: “Participants
were randomised to intervention or control
groups using a computer-generated ran-
domization sequence that was entered into
numbered, opaque, sealed envelopes by a
study investigator (TH)”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible due to
nature of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement comment: Quote: “A 12-
month telephone follow-up assessment was
also completed by researchers blinded to
participant group allocation using a tele-
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phone version of the EQ-5D with VAS in-
strument, whilst also enquiring of sustained
adherence to the allocated intervention”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: recruited: 89; fol-
low-up: 73. Consort provided (attrition
18%)
Selective reporting (reporting bias) Low risk Judgement comment: All outcome mea-
sures were reported.
Other bias High risk Judgement comment:
1. This exercise intervention was reported
as a 12-month intervention. However all
measures except EQ-5D were reported at
6 months while EQ-5D was reported at
12 months over the telephone. Quote:
“Face-to-face follow-up assessments coin-
cided with follow-up appointments at the
Breast Clinic at 3 and 6 months. A 12-
month telephone follow-up assessment was
also completed by researchers blinded to
participant group allocation using a tele-
phone version of the EQ-5D with VAS in-
strument, whilst also enquiring of sustained
adherence to the allocated intervention”
2. The control group was a sham group.
Quote: “The final limitation was that the
sham interventionmay have had some ben-
eficial effects. This combined with the pre-
vious limitation would lead the authors to
consider that the estimates of intervention
efficacy established through this trial are
likely to be conservative”
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Methods Study design: two-arm randomised controlled trial
Methods of participant recruitment: not reported
Aim of study: Quote: “To investigate the effects of a scheduled home-based exercise
intervention in breast cancer patients during adjuvant chemotherapy, on cancer-related
fatigue, physical fitness, and activity level”
Start date of study: 2010
End date of study: 2012
Total study duration: 2 years
Country: Norway
Sample size: 60
Duration of follow-up: 18 to 24 weeks
Study funding source: A PhD scholarship was funded by governmental funds allocated
to the University of Stavanger
Declarations of conflict of interest: none declared
Participants Included criteria:Quote: “Eligible breast cancer patients were between 18 and 70 years
of age, surgically treated for early stage breast cancer (mastectomy or lumpectomy), and
allocated to adjuvant chemotherapy according to the national treatment guidelines of
theNorwegian Breast Cancer Group. The included patients had to be able to read, write,
and speakNorwegian, and they were approved for participation in this study by a clinical
oncologist”
Excluded criteria: not reported
Baseline imbalances: no differences reported on demographics and characteristics of
study population table
Total no. randomised: 67
No. intervention group: 33
No. control group: 34
Age (years):
Intervention: 50.8 ± 9.7
Control: 53.6 ± 8.8
Gender: female
Race/ethnicity: intervention: Norwegian: 27; other: 5; missing: 1; control: Norwegian:
30; Other: 4; Missing: 0
Cancer type: breast cancer stage I or II
Cancer treatment: chemotherapy (n = 33), other systemic treatment (n = 56) and
radiotherapy (n = 48)
Attrition rate: 29.9%
No. intervention group assessed at follow-up time point: completion of chemotherapy
(18-24 weeks) (29)
No. control group assessed at follow-up time point: completion of chemotherapy (18-
24 weeks) (31)
Reasons for withdrawal: Due to Norwegian Research Ethics Legislation, study partic-
ipants were not obligated to give a reason for withdrawal, and the researchers were not
allowed to ask
Interventions Intervention characteristics
• Setting: home-based
• Group/non-group based: alone
• Frequency: aerobic: daily, strength: 3 sessions/week
• Intensity: aerobic: moderate, strength: 1-3 sets for 20 repetitions
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• Time: aerobic: 30 mins (could be split into 10 mins periods), strength: not
reported
• Type: aerobic: walking, strength: resistance bands for arms and legs/strength
training for the upper body
• Monitoring during exercise: Quote: “The women in the intervention group were
supported and encouraged in their exercise by motivational telephone calls from the
research team every second week. The telephone calls were also used to monitor adverse
events. The women in the control group were encouraged to remain on their regular
activity level and received one follow-up call during the intervention time period”.
• Support source: phone call from member of research team
• Adherence: aerobic: 17% to the trial prescription; resistance: 15%
• Adverse events: Quote: “One participant in the intervention group reported knee
discomfort and was referred to her primary physician for further evaluation. The
patient stayed in the trial and completed the exercise prescription. Another participant
in the intervention group experienced syncope during the walking exercise. This was
related to a secondary chronic condition, and the patient was advised by her oncologist
to withdraw from the trial”.
Outcomes Aerobic fitness (6-minute walk test)
• Outcome type: continuous
• Unit of measure: metres
• Direction: higher is better
Physical activity (International physical activity questionnaire)
• Outcome type: continuous
• Unit of measure: met-minute/week
• Direction: higher is better
Fatigue (Schwarts Cancer Fatigue Scale (SCFS-6)
• Outcome type: continuous
• Scale: 6-30
• Direction: lower is better
Identification Setting: University Hospital Norway
Authors name: Husebo AL
Institution: University of Stavanger
Email: anne-marie.l.husebo@uis.no
Address: Department of Health Studies, Univeristy of Stavanger, 4036 Stavanger, Nor-
way
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment: Quote: “The ran-
dom assignment of subjects to the interven-
tion group or to the control group was car-
ried out by the use of concealed envelopes,
drawn by the research assistant prior to the
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first data collection”
Allocation concealment (selection bias) Low risk Judgement comment: Quote: “The ran-
dom assignment of subjects to the interven-
tion group or to the control group was car-
ried out by the use of concealed envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible due to
the nature of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Judgement comment: not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk Judgement comment: consented 67, com-
pleted 53. Consort provided (attrition 29.
9%)
Selective reporting (reporting bias) Low risk Judgement comment: All outcome mea-
sures were reported.
Other bias Low risk Judgement comment: none identified
Hwang 2008
Methods Study design: randomised controlled trial
Methods of participant recruitment: Quote: “consecutive unselected women on the
outpatient waiting list for radiotherapy for breast cancer approached at their first planned
visit”
Aim of study: Quote: “to determine whether supervised and structured moderate-in-
tensity exercise during radiotherapy would offer some benefit to breast cancer patients
by improving QOL and shoulder mobility and reduce levels of fatigue and pain”
Start date of study: not reported
End date of study: not reported
Total study duration: not reported
Country: Korea
Sample size: 40
Duration of follow-up: 5 weeks
Study funding source: not reported
Declaration of conflict of interest: not reported
Participants Included criteria:Quote: “consecutive unselected women on the outpatient waiting list
for radiotherapy for breast cancer”
Excluded criteria: Quote: “The exclusion criteria included concurrent major health
problems that could affect their participation in an exercise program, including uncon-
trolled hypertension, cardiovascular disease, acute or chronic respiratory disease, and
cognitive dysfunction”
Baseline imbalances:Quote: “There were no significant differences in all of the outcome
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measures at the baseline between groups”
Total no. randomised: 40
No. intervention group: 17
No. control group: 20
Age (years):
Intervention: 46.3 ± 7.5;
Control: 46.3 ± 9.5
Gender: female
Race/ethnicity: not reported
Cancer type: breast cancer
Cancer treatment: adjuvant radiotherapy. Quote: “Patients were irradiated with a dose
of 50 Gy during 5 weeks with a dose per fraction of 2 Gy”
Attrition rate: 7.5%
No. intervention group assessed at follow-up time point: 5 weeks (17)
No. control group assessed at follow-up time point: 5 weeks (20)
Reasons for withdrawal:
Intervention (n = 0)
Control (n = 3) as they did not want to participate in follow-up assessment
Interventions Intervention characteristics
• Setting: not clear (supervised)
• Group/non-group based: not reported
• Frequency: 3 sessions/week
• Intensity: aerobic: 50%-70% age-adjusted heart rate maximum
• Time: 50 min (10-min warm up, 30-min exercise (including stretching exercises
focused on shoulders, aerobic exercise such as treadmill walking and bicycling, and
strengthening exercise) and 10-min cool down (relaxation period)
• Type: aerobic: treadmill and bicycling, strength: not reported
• Monitoring during exercise: not reported
• Support source: not reported
• Adherence: not reported
• Adverse events: Quote: “No significant exercise-related adverse events such as
lymphedema were reported”.
Outcomes HRQoL (World Health Organisation quality of life (WHOQOL) overall quality of life
subscale)
• Outcome type: continuous
• Scale: 1-5
• Direction: higher is better
HRQoL (WHOQOL overall health subscale)
• Outcome type: continuous
• Scale: 1-5
• Direction: higher is better
HRQoL (World Health Organisation quality of life (WHOQOL) physical subscale)
• Outcome type: continuous
• Scale: 4-20
• Direction: higher is better
HRQoL (WHOQOL psychological subscale)
• Outcome type: continuous
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• Scale: 4-20
• Direction: higher is better
HRQoL (WHOQOL social subscale)
• Outcome type: continuous
• Scale: 4-20
• Direction: higher is better
HRQoL (WHOQOL environmental subscale)
• Outcome type: continuous
• Scale: 4-20
• Direction: higher is better
Fatigue (Brief fatigue inventory (BFI))
• Outcome type: continuous
• Scale: 0-10
• Direction: lower is better
Identification Setting: not reported
Authors name: Dr. Hyun Jung Chang
Institution:Department of Physical Medicine Rehabilitation, SamsungMedical Center
Email: reh.chj@gmail.com
Address: Department of Physical Medicine Rehabilitation, Samsung Medical Center,
SungkyunkwanUniversity School ofMedicine, 50 Ilwon-dong,Gangnam-gu, Seoul 135-
710, Korea
Notes Control groupwere shownhow toperform shoulderROMexercises andwere encouraged
to continue normal activities
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement comment: not reported
Allocation concealment (selection bias) Unclear risk Judgement comment: not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible due to
nature of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Judgement comment: not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: consented 40, com-
plete 37 (attrition 7.5%)
Consort not provided, but numbers were
clearly stated. Quote: “Forty participants
were recruited and randomly assigned to
either an exercise or control group. Three
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patients in the control group were lost dur-
ing follow-up because they did not want to
participate in follow-up measurements. Fi-
nally, 37 patients completed the follow-up
assessment (17 in the exercise group, 20 in
the control group)”
Selective reporting (reporting bias) Unclear risk Judgement comment: results are not clearly
described according to primary/secondary
Other bias Low risk Judgement comment: none identified
May 2017
Methods Study design: two-arm randomised controlled trial
Methods of participant recruitment: Participants were invited by their clinician or
oncological nurse during a regular outpatient clinic visit. Quote: ”Breast cancer patients
willing to participate were asked to visit the study centre to confirm eligibility and sign
informed consent“
Aim of study: Quote: “To assess the cost-effectiveness of the 18 week physical activity
during cancer treatment (PACT) intervention for patients with breast and colon cancer.
The PACT trial showed beneficial effects for fatigue and physical fitness”
Start date of study: 2010
End date of study: 2013
Total duration of study: 3 years
Country: Netherlands
Sample size: 150
Duration of follow-up: 18 weeks
Study funding source:Quote: This work was supported by The Netherlands Organisa-
tion forHealth Research andDevelopment (ZonMw, project number: 171 002 202), the
Dutch Cancer Society (KWF Kankerbestrijding, project number: UU 2009-4473) and
the Dutch Pink Ribbon Foundation (2011.WO02.C100). All grants are unrestricted”
Declarations of conflict of interest: none declared
Reference of a separate article published on this trial (data of which are reported here)
. Reference: Travier N, Velthuis MJ, Steins Bisschop, Van den Buijis B, Monninkhof
EM, Backx F, et al. Effects of an 18-week exercise programme started early during breast
cancer treatment: a randomised controlled trial. BMC Medicine 2015; 13: 121
Participants Included criteria:Quote: “The inclusion criteria were a definitive full histological breast
cancer diagnosis < 6 weeks before recruitment; stage M0 (i.e., no distant metastasis);
scheduled for chemotherapy (as part of the treatment regimen); aged 25 to 75 years; not
treated for any cancer in the preceding 5 years (except basal skin cancer); able to read
and understand the Dutch language; Karnovsky Performance Status of ≥ 60; and no
contraindications for physical activity. Inclusion was irrespective of the patients’ current
physical activity level“
Excluded criteria: not reported
Total no. randomised: 204
Total no. intervention group: 102
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Total no. control group: 102
Age (years):
Intervention: breast: 50.0 ± 7.9, colon: 49.4 ± 7.6;
Control: breast: 49.4 ± 7.6, colon 59.1 ± 8.9
Gender: intervention (breast: 87 female; colon: 7 male and 7 female); control (breast:
78 female; colon: 11 male and 4 female)
Race/ethnicity: not reported
Cancer type: breast and colon
Cancer treatment: adjuvant chemotherapy and radiotherapy. Quote: ”Neo-adjuvant
chemotherapy was still rare, and was used in less than 5% of PACT participants“
Intervention: breast (60 radiotherapy and 54 chemotherapy); colon (1 radiotherapy and
14 chemotherapy)
Control: breast (52 radiotherapy and 53 chemotherapy); colon (1 radiotherapy and 15
chemotherapy)
Attrition rate: 19.6%
No. intervention group assessed at follow-up time point: 20 weeks (101)
No. control group assessed at follow-up time point: 20 weeks (93)
Reasons for withdrawal:
Intervention (n = 13): logistic reasons 1, disappointment because of randomisation 2,
mental burden 4, unknown 6
Control (n = 9): medical reasons 3, mental burden 3, problems with travelling 1, died
1, unknown reason 1
Interventions Intervention characteristics
• Setting: hospital-based
• Group/non-group based: one-to-one
• Components of programme: aerobic and strength (upper/lower)
• Frequency: 2/week
• Intensity: Aerobic: interval (alternating intensity performed with heart rate at (3x2
min increasing to 2x7 min) or below (3x4 min decreasing to 1x7min) ventilatory
threshold. Strength: 2x10 (65% one-repetition maximum) and gradually increased to
reach 1x10 repetitions (75 one-repetition maximum) and 1x20 repetitions (45% one-
repetition maximum) by end of programme.
• Time: 60 min (5 min warm-up, 25 min each of aerobic and muscle strength
training, 5 min cool down)
• Type: patient preference (types not reported)
• Monitoring during exercise: heart rate (method not reported) and RPE scale
• Support source: Quote: ”The Netherlands Organisation for Health Research and
Development (ZonMw, project number: 171002202), the Dutch Cancer Society
(KWF Kankerbestrijding, Project number: UU 2009-4473), and the Dutch Pink
Ribbon Foundation (2011.WO02.C100). The contribution of N Travier was
supported by the Spanish Ministry of Health (Instituto de Salud Carlos III RTICC
RD06/0020/0091 and RD12/0036/0018)“.
• Adherence: 83%
• Adverse events: No serious adverse events related to exercise were observed during
the study period.
Outcomes Aerobic fitness (cardiopulmonary exercise test (CPET) on a cycle ergometer)
• Outcome type: continuous
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• Unit of measure: L/min
• Direction: higher is better
Upper body strength: handgrip (right/left) (note right and left arm data were averaged
for the purpose of the meta-analyses as all other studies did not report which arm the
test was conducted on)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Lower body muscle strength (mechanical handgrip dynamometer): right/left knee ex-
tensor/flexor peak torque at 60o/s
• Outcome type: continuous
• Unit of measure: Nm
• Direction: higher is better
Lower body muscle strength (mechanical handgrip dynamometer): right/left knee ex-
tensor/flexor peak torque at 180o/s
• Outcome type: continuous
• Unit of measure: Nm
• Direction: higher is better
Physical activity levels (Short QUestionnaire to ASessHealth enhancing physical activity
(SQUASH)
• Unit of measure: minutes per week of moderated to high total physical activity
and leisure and sport activity
• Direction: higher is better
HRQoL (EQ-5D utility)
• Outcome type: continuous
• Scale: 0.59-1
• Direction: higher is better
HRQoL (EORTC QLQ-C30 subscales)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
HRQoL (SF-36)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
Fatigue (multidimensional fatigue inventory (MFI)
• Outcome type: continuous
• Scale: 4-20
• Direction: lower is better
Identification Setting: outpatient clinics of 7 hospitals in the Netherlands (1 academic and 6 general
hospitals)
Authors name: Dr Anne M. May
Institution: UMC Utrecht
Email: A.M.May@umcutrecht.nl
Address: not reported
Notes Some data were taken from a separate publication linked to this study. Reference: Travier
N, Velthuis MJ, Bisschop CNS, Van der Buijs B, Monninkhof EM, Backx F, et al.
Effects of an 18-week exercise programme started early during breast cancer treatment:
53Exercise interventions for people undergoing multimodal cancer treatment that includes surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
May 2017 (Continued)
a randomised controlled trial. BMC Medicine 2015; 13 (121)
Interventional notes were as follows:
Quote: ”Training intensity was re-evaluated every 4 weeks by submax cardiopulmonary
exercise testing (CPET) and 1-repition maximum (RM)“
Quote: ”Participants in the intervention group were encouraged to be physically active
for at least 30 min on at least three other days as recommended by Dutch guidelines“
Quote: ”Heart rate and the Borg scale of perceived exertion were monitored during the
aerobic training“
Quote: ”Participants randomised to control received usual care and were asked to main-
tain their habitual physical activity pattern up to week 18“
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”A concealed computer-generated
randomisation, following a 1:1 ratio, strati-
fied per age, adjuvant treatment (radiother-
apy yes/no before chemotherapy), use of
tissue expander, and hospital by sequential
balancing, was used to allocate participants
to study groups“
Allocation concealment (selection bias) Low risk Judgement comment: as above: Quote:
“Concealed randomisation of patients...”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: Quote: “Blinding of
participants was not possible due to the na-
ture of the study”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement comment: Quote: “outcome
measures were assessed by researchers not
involved with the participants”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: consented 204; com-
pleted 164. Consort not provided in this
article but it is in other related article (at-
trition 19.6%)
Selective reporting (reporting bias) Low risk Judgement comment: All outcome mea-
sures were reported according to methods
Other bias Low risk Judgement comment: none identified
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Methods Study design: two-arm randomised controlled trial
Methods of participant recruitment: Quote: “Potential participants were identified
from new patient appointment lists at the site clinics between 1998 and 2001 and
approached by investigators during their consultation visits prior to initiating adjuvant
therapy”
Aim of study:Quote: “To conduct a randomised controlled trial to determine the effects
of a home-based walking exercise program on levels of fatigue in women with breast
cancer receiving adjuvant cytotoxic chemotherapy or radiation therapy”
Start date of study: 1998
End date of study: 2001
Total study duration: 3 years
Country: United States
Sample size: 120
Duration of follow-up: The exercise programme was implemented to span the period
of time from initiation to cessation of adjuvant therapy: 6 weeks of radiotherapy or 3-6
months of chemotherapy
Study funding source: Quote: “This study was funded by a competitive FIRE1 (Fa-
tigue Initiative in Research and Education) multi-institutional award from theOncology
Nursing Society Foundation to Dr Mock under the aegis of the Johns Hopkins Univer-
sity”
Declaration of conflict of interest: not reported
Participants Included criteria:Quote: “Women aged 18-70 years of age, treated for Stage 0-III breast
cancer by definitive surgery and scheduled to receive outpatient radiation therapy or
adjuvant chemotherapy were eligible for the study”
Excluded criteria: Quote: “Exclusion criteria included concurrent major health prob-
lems that could affect participation in an exercise program, including obesity (body mass
index > 35 kg/m2), cardiovascular disease, acute or chronic respiratory disease, and cog-
nitive dysfunction. Also ineligible for study participation were patients already engaged
in active exercise, defined as exercising more than 45 min per week”
Baseline imbalances: Yes: Quote: “The baseline covariates were balanced between the
randomised groups except for the 12-min walk performance”
Aim of study:Quote: “To conduct a randomised controlled trial to determine the effects
of a home-based walking exercise program on levels of fatigue in women with breast
cancer receiving adjuvant cytotoxic chemotherapy or radiation therapy”
Total no. randomised: 119
No. intervention group: 60
No. control group: 59
Age (years):
Intervention: 51.3 ± 8.9
Control: 51.6 ± 9.7
Gender: female
Race/ethnicity: Quote: “Caucasian (intervention: 85%, control: 79.3%)”
Cancer type: breast cancer stage O-III
Cancer treatment: adjuvant cytotoxic chemotherapy/radiation therapy:
Intervention: chemotherapy (41.7%), radiotherapy (58%)
Control: chemotherapy (42.4%) ,radiotherapy (57.6%)
Attrition rate: 9.3%
No. intervention group assessed at follow-up time point: not clearly stated (dependent
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on treatment type) (n = 54)
No. control group assessed at follow-up time point: not clearly stated (dependent on
treatment type) (n = 54)
Reasons for withdrawal:
Intervention (n = 6): radiotherapy: patient request (1); chemotherapy: moved and with-
drew from care at site (1), withdrew from chemotherapy (2), allergic reaction to chemo-
therapy (1), patient request (1)
Control (n = 5): radiotherapy: patient request (1); chemotherapy: patient request (1)
and did not complete post-test (3)
Interventions Intervention characteristics
• Setting: home-based
• Group/non-group based: alone
• Frequency: 5-6 times/week
• Intensity: moderate pace in target heart range (approx. 50%-70% of MHR)
• Time: 15 mins walk increasing to 30 mins as training progressed
• Type: walking
• Monitoring during exercise: heart rate. Quote: “all exercise participants kept daily
diaries of exercise periods including pulse rates, perceived exertion rates and fatigue
levels”. Note: method of measuring pulse rate not clear
• Support source: phone call from member of research team: Quote: “Contacted
every 2 weeks by research team to evaluate the prescription and participant progress”.
• Adherence: participants on chemotherapy (75%) and on radiotherapy (71%)
• Adverse events: No adverse events attributable to the walking exercise program
were reported or observed in the study.
• Withdrawals: Intervention: radiotherapy: patient request (1); chemotherapy:
moved and withdrew from care at site (1), withdrew from chemotherapy (2), allergic
reaction to chemotherapy (1), patient request (1), Control: 5: radiotherapy: patient
request (1); chemotherapy: patient request (1) and did not complete post-test (3)
Outcomes Aerobic fitness (12-min walk test)
• Outcome type: continuous
• Direction: higher is better
Physical activity levels (physical activity questionnaire)
• Outcome type: continuous
• Unit of measure: metabolic equivalents and kilocalories
• Direction: higher is better
Fatigue (Total score of the Piper Fatigue scale (PFS)
• Outcome type: continuous
• Scale: 0-10
• Direction: lower is better
Identification Sponsorship source: not reported
Country: United States
Setting: 4 university teaching hospitals for National Cancer Institute designated cancer
centres and 4 community cancer centres in eastern United States
Authors name: Mock, V
Institution: Center for Nursing Research, Johns Hopkins University
Email: vmock@son.jhmi.edu
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Address: Center for Nursing Research, Johns Hopkins University, P.O. Box 50250,
Baltimore, MD 21211- 4250, USA
Notes 1. Programme was detailed in a booklet and video provided to patients in the exercise
group to ensure standardisation across subjects and across 8 clinical sites
2. Patients in the control group were encouraged to maintain current PA levels but no
exercise prescription or formal programs were offered
3. All participants in the intervention group kept exercise diaries detailing pulse rates,
RPE, and fatigue levels. These diaries were sent to the data coordinating centre each
week
4. Exercising participants were contacted by the research team every twoweeks to evaluate
their prescription and progress
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment: Quote: “Consecu-
tively numbered sealed opaque envelopes
containing the computer-generated ran-
domization assignments were prepared at
the coordinating center and opened at the
site following baseline pre-testing for each
participant”
Allocation concealment (selection bias) Low risk Judgement comment: Quote: “Consecu-
tively numbered sealed opaque envelopes
containing the computer-generated ran-
domization assignments were prepared at
the coordinating center and opened at the
site following baseline pre-testing for each
participant”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: Quote: “It is a limi-
tation of the study that members of the re-
search staff were not blind to participants’
group assignment”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Judgement comment: not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: consented 119, com-
pleted 108. Consort provided (attrition 9.
3%)
Selective reporting (reporting bias) High risk Judgement comment: Outcome measures
were clearly defined however within the re-
sults section following reporting of non-
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significant findings, the authors allocated
the exercise group into high and low walk-
ers (this was not stated within themethods)
Other bias Low risk Judgement comment: none identified
Reis 2013
Methods Study design: two-arm randomised controlled trial
Aim of study: Quote: “to compare the effects of a 12-week Nia program to usual care
in women with breast cancer undergoing radiation therapy to further test Nia in cancer
and cancer treatment rehabilitation”
Methods of recruitment of participants: not reported
Study start date: Nov 2008
Study end date: Jan 2010
Total study duration: 14 months
Country: United States
Sample size: 41
Duration of follow-up: 12 weeks
Study funding source: Oncology Nursing Foundation
Declaration of conflict of interest: none
Participants Included criteria:Quote: “All women aged18 years andolder receiving radiation therapy
for stage I, II, or III breast cancer”
Excluded criteria: Under 18 years old, non-English speaking, breast cancer stage 0 or
stage 4
Baseline imbalances: no
Total randomised: 41
No. intervention group: 22
No. control group: 19
Age (years):
Intervention: 54 ± 11.1
Control: 59 ± 10.7
Gender: female
Race/ethnicity:
Intervention: Caucasian (20); African American (1); other (1)
Control: Caucasian (17); African American (2); other (-)
Cancer type: breast (stage I, II, III)
Cancer treatment: radiation
Attrition rate: 29.3%
Quote: “Note. For the Nia intervention group, n = 12; for the control group, n = 17.
Total participant count for this analysis is 29”
Reasons for withdrawal: illness and loss of strength (numbers not provided)
Interventions Intervention characteristics
• Setting: home-based
• Group/non-group based: alone
• Frequency: 3 sessions/week
• Intensity: not reported. Quote: “The practice of Nia can be gentle for individuals
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with a sedentary lifestyle or challenging for those with an active lifestyle (Rosas Rosas,
2004). Therefore, the adaptive nature of Nia may be of enhanced benefit to individuals
with cancer”.
• Time: 20-60 mins
• Type: not reported
• Monitoring during exercise: The PI met participants at week 6 and week 12 to
review their ability and how to modify movements to enhance their Nia practice. The
PI met with control group to instruct them to maintain current exercise regimen. Both
groups kept exercise logs during the 12-week study period.
• Support source: as per above
• Adherence: intervention: 2 days/week Nia + 2/sessions/week of other aerobic
exercise
• Adverse events: none reported
Outcomes Aerobic fitness (6-minute walk test)
• Outcome type: continuous
• Unit of measure: metres
• Direction: higher is better
HRQoL (Functional assessment of cancer therapy-General (FACT-G)
• Outcome type: continuous
• Scale: 0-108
• Direction: higher is better
HRQoL (FACT-G subscale physical well-being)
• Outcome type: continuous
• Scale: 0-28
• Direction: higher is better
HRQoL (FACT-G subscale social or family)
• Outcome type: continuous
• Scale: 0-28
• Direction: higher is better
HRQoL (FACT-G subscale functional well-being)
• Outcome type: continuous
• Scale: 0-28
• Direction: higher is better
Fatigue (FACT-G subscale fatigue)
• Outcome type: continuous
• Scale: 0-52
• Direction: higher is better
Fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale
• Outcome type: continuous
• Scale: 0-160
• Direction: higher is better
Identification Setting: Flower Hospital, community-based hospital in north-west Ohio
Authors name: Reis, D
Institution: not reported
Email: deb.reis@promedica.org
Address: not reported
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Notes Interventional notes are as follows:
Quote: “Nia, which focuses on the body, mind, and spirit. Nia is a cardiovascular and
whole-body conditioning program that integrates five sensations: strength, flexibility,
mobility, agility, and stability (Rosas Rosas, 2004). Nia is based in nine movement forms:
three martial arts (TaiChi, Tae Kwon Do, and Aikido), three dance arts (jazz dance,
modern dance, and Duncan dance), and three healing arts (yoga, the teachings ofMoshe
Feldenkrais, and the Alexander Technique)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment: Randomisation was
stratified by stage of disease (I, II, III) and
age (59 or younger, 60 and older) in an
attempt to ensure equal representation of
these groups in both interventions
Allocation concealment (selection bias) Low risk Judgement comment: Envelopes were
sealed with group assignment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: not possible in this
type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Judgement comment: Outcome assessors
were not blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk Judgement comment: consented 41, com-
pleted 29 (attrition 29.3%)
Quote: “For the Nia intervention group, n
= 12; for the control group, n = 17. Total
participant count for this analysis is 29”
Selective reporting (reporting bias) Low risk Judgement comment: All outcomes were
reported clearly.
Other bias Low risk Judgement comment: none identified
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Methods Study design: three-armed randomised controlled trial
Methods of recruitment of participants: Quote: “Potentially eligible patients with
breast cancer were identified through hospital records, whereas patients with colon cancer
were identified by their treating physicians”
Aim of study:Quote: “to evaluate the effectiveness of a home-based, low-intensity phys-
ical activity program (Onco-Move) and a supervised, moderate- to high-intensity, com-
bined resistance and aerobic exercise program (OnTrack) in maintaining or enhancing
physical fitness and minimizing fatigue in patients undergoing adjuvant chemotherapy”
Start date of study:March 2010
End date of study: December 2012
Total study duration: 33 months
Country: Netherlands
Sample size: 192
Duration of follow-up: end of cancer treatment (estimated between 117 and 119 days
(17 weeks)
Study funding source: Quote: “Supported by Alpe d’Huzes/Dutch Cancer Society
Grant No. ALPE-2009-4299, the CZ Fund, Zilveren Kruis Achmea, and the Compre-
hensive Cancer Centre of the Netherlands”
Declarations of conflict of interest: none declared
Participants Included criteria: Quote: “Patients were eligible for the trial if they had histologically
confirmed primary breast or colon cancer and were scheduled to undergo adjuvant
chemotherapy at one of 12 hospitals in the Amsterdam region of the Netherlands”
Excluded criteria: Quote: “Patients were excluded if they had serious orthopedic, car-
diovascular, or cardiopulmonary conditions, were suffering from malnutrition, had se-
rious psychiatric or cognitive problems, or did not have basic fluency in Dutch. There
was no upper age limit”
Baseline imbalances: Quote: “Baseline characteristics were balanced across groups”
Gender: female and male
Population: breast and colon cancer (however data for the breast cancer participants
were only reported due to small sample)
Total no. randomised: 230
Total no. intervention group 1: 76
Total no. intervention group 2: 77
Total no. control group: 77
Race/ethnicity: not reported
Cancer type: breast and colon cancer (however analysis only focused on breast cancer
due to the low number with colon cancer)
Cancer treatment: adjuvant chemotherapy
Age (years):
Intervention 1 (OnTrack): 49.9 ± 8.4
Intervention 2 (Onco-Move): 50.5 ± 10.1
Control: 51.6 ± 8.8
Attrition rate: 14.4%
No. intervention group 1 assessed at follow-up: end of chemotherapy (71)
No. intervention group 2 assessed at follow-up: end of chemotherapy (69)
No. control group assessed at follow-up: end of chemotherapy (66)
Reasons for withdrawal:
Intervention 1: too ill (2), physical accident unrelated to trial (1), physical accident
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related to trial (1), unwilling (1)
Intervention 2: neuropathy (1); emigrated (1); unwilling (6)
Control: too ill (2), unwilling (7), unknown (2)
Interventions Intervention characteristics
Intervention 1 (On Track)
• Setting: community (supervised by community-based physiotherapists who had
received training in the intervention and were part of an oncology-physiotherapy
network. Every attempt was made for patients to avail of a physiotherapist located close
to their home).
• Group/non-group based: alone
• Frequency: 2 sessions/week
• Intensity: aerobic: 50%-80% maximal workload (steep ramp test) and BORG scale
(less than 12 for increase and more than 16 for a decrease), strength: 80% 1 rep max
• Time: aerobic: 30 mins, strength: 20 mins
• Type: aerobic and strength (upper and lower limb): not reported
• Source of support: not reported if any
• Adherence: 71%
• Monitoring during exercise: not reported if any
• Adverse events: none
Intervention 2 (Onco-Move)
• Setting: home-based
• Supervision: unsupervised
• Group/non-group based: alone
• Duration of exercise programme: started with the first cycle of chemotherapy and
continued until 3 weeks after the last cycle (varied per patient)
• Components of the exercise programme: aerobic
• Frequency: 5 days/week
• Intensity: 12-14 BORG scale
• Time: 30 mins
• Type: walking
• Source of support: Participants received encouragement from a nurse in the
chemotherapy unit to be physical active at least 30 minutes per day. This
encouragement was provided each time the nurse saw the patient.
• Adherence: 55%
• Monitoring during exercise: not reported if any
• Adverse events: none
Outcomes Aerobic (steep ramp test: maximal short exercise capacity)
• Outcome type: continuous
• Unit of measure: minutes
• Direction: higher is better
Aerobic fitness (endurance time)
• Outcome type: continuous
• Unit of measure: watts
• Direction: higher is better
Upper body muscle strength (elbow flexion)
• Outcome type: continuous]
• Unit of measure: Newton meters (Nm)
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VanWaart 2015 (Continued)
• Direction: higher is better
Upper body muscle strength (grip strength dynamometer)
• Outcome type: continuous
• Unit of measure: kg
• Direction: higher is better
Lower body muscle strength (knee extension)
• Outcome type: continuous
• Unit of measure: Nm
• Direction: higher is better
Lower body muscle strength (30-sec chair stand)
• Outcome type: continuous
• Unit of measure: seconds
• Direction: higher is better
Physical activity levels (Physical Activity Scale for the Elderly)
• Outcome type: continuous
• Direction: higher is better
HRQoL (EORTC QLQ-C30 subscales)
• Outcome type: continuous
• Scale: 0-100
• Direction: higher is better
Fatigue (EORTC QLQ-C30 subscale)
• Outcome type: continuous
• Scale: 0-100
• Direction: lower is better
Fatigue (multidimensional fatigue inventory (MFI)
• Outcome type: continuous
• Scale: 4-20
• Direction: lower is better
Identification Setting: 12 hospitals in the Amsterdam region of the Netherlands
Authors name: Neil K. Aaronson
Institution: Division of Psychosocial Research and Epidemiology, Netherlands Cancer
Institute
Email: n.aaronson@nki.nl
Address: Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the
Netherlands
Notes 1. Participants in the OnTrack group were also encouraged to be physically active 5 days
each week for 30 minutes per session and to keep an activity diary
2. Each participant in the OncoMove group had an activity diary that was discussed at
each chemotherapy cycle. Specially trained nurses encouraged participants to engage in
exercise
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement comment: email reply from
main author: “We used a computer pro-
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VanWaart 2015 (Continued)
gram specifically designed to carry out a
minimisation process for assigning patients
to one of the three trial groups. The study
staff that carried out the randomisation
used that program”
Allocation concealment (selection bias) Low risk Judgement comment: email reply from
main author: “We used a computer pro-
gram specifically designed to carry out a
minimisation process for assigning patients
to one of the three trial groups. The study
staff that carried out the randomisation
used that program”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Judgement comment: due to the nature of
the intervention, blinding of participants
and personnel not possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Judgement comment: Author email replied
to email to say that the outcome assessors
were not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement comment: consented 230, com-
pleted 197. Consort provided (attrition 14.
4%)
Selective reporting (reporting bias) High risk Judgement comment: data not reported.
Quote: “There were no other significant
group differences at T1 or T2 for the re-
maining EORTC QLQC30 scales or the
measures of psychological distress (Hospi-
tal Anxiety and Depression Scale), func-
tioning in daily life (Impact on Participa-
tion and Autonomy instrument), or self-re-
ported activity level (Physical Activity Scale
for the Elderly; data not shown)”
Other bias Low risk Judgement comment: none identified
ANC:Absoluteneutrophilcount
BFI: Brief fatigue inventory questionnaire
BORG: Borg rating of perceived exertion
CBC: Complete blood count
CPET: Cardiopulmonary exercise test
ECOG: European cooperative oncology group
EORTC QLQ-C30: European organisation for research and treatment of cancer questionnaire
EQ-5D: standardised instrument for measuring general health status
FACIT-F: Functional assessment of chronic illness therapy - Fatigue
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FACT-G: Functional assessment of chronic illness therapy - General
GH: General health perception
HRQoL: Health related quality of life
IQR: Interquartile range
MET: Metabolic equivalent threshold
MFI: Multidimensional fatigue inventory
MHR: Maximal heart rate
MOS: Medical outcome study NA: Not applicable
PA: Physical activity
PACT:Physcial activity during cancer intervention trial
PFS: Piper fatigue scale
PI: Principle investigator
ROM: Range of motion
RPE: Rating of perceived exertion
SCFS-6: Shwartz cancer fatigue scale
SF-36: Short form health survey
SMS: Short message service
SQUASH: Short questionnaire to assess health enhancing physical activity
VAS: Visual analogue scale
VO2 max: Oxygen uptake at maximal capacity
WHOQOL: World health organisation quality of life
YG: Yoga group
1RM: 1-repeition maximum
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ahmed 2006 Wrong patient population
Bloomquist 2014 Wrong patient population
Cadmus 2009 Wrong patient population
Cho 2008 Wrong study design
Coleman 2003 Wrong study design
Coleman 2008 Wrong patient population
Courneya 2008 Wrong study aim
Courneya 2009 Wrong patient population
Courneya 2014 Wrong comparator
Devoogdt 2011 Wrong patient population
65Exercise interventions for people undergoing multimodal cancer treatment that includes surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Dimeo 1997 Wrong patient population
Duijts 2012 Wrong setting
Harder 2015 Wrong setting
Jones 2010 Wrong study design
Kilbreath 2012 Wrong setting
McNeely 2008 Wrong patient population
McNeely 2010 Wrong study design
Mina 2014 Wrong patient population
Pehlivan 2011 Wrong patient population
Salhi 2014 Wrong study design
Salhi 2015 Wrong setting
Saxton 2014 Wrong patient population
So 2006 Wrong study design
Song 2013 Wrong intervention
Thorsen 2005 Wrong setting
Villanueva 2011 Wrong patient population
Xu 2015 Wrong intervention
Characteristics of ongoing studies [ordered by study ID]
Loughney 2016
Trial name or title The EMPOWER trial: The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training
programme on physical fitness and quality of life in locally advanced rectal cancer patients: study protocol
for a randomised controlled trial
Methods 2-arm RCT (target sample 46)
Participants Colorectal cancer (neoadjuvant treatment)
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Loughney 2016 (Continued)
Interventions In-hospital supervised exercise training
Quote: “Patients are requested to attend three in-hospital exercise training sessions per week for 6 to 9 weeks
(dependent on the time interval between neoadjuvant CRT and surgery at each hospital). The exercise training
is an aerobic interval exercise training programme incorporating moderate and severe intensities”
Outcomes Physical fitness (cardiopulmonary exercise test)
Physical activity (sense wear activity monitoring)
Starting date October 2013 (end date: Dec 2017) results being prepared for publication (2018)
Contact information Dr Sandy Jack, PhD, s.jack@soton.ac.uk
Notes ClinicalTrials.gov identifier: NCT01914068
Country: United Kingdom
Morielli 2018
Trial name or title Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a ran-
domised controlled trial
Methods 2-arm RCT (target sample 60)
Participants Rectal cancer (neoadjuvant treatment)
Interventions Supervised & non-supervised exercise training
“Participants in the exercise training group will be asked to complete three supervised, high-intensity interval
training sessions/week duringNACRTand≥ 150min/week of unsupervised,moderate-to-vigorous-intensity,
continuous exercise training after NACRT prior to surgery”
Outcomes Cardiorespiratory fitness (VO2 peak)
Quality of life (European Organisation of Research and Treatment of Cancer, and symptom management
assessed by the M.D. Anderson Symptom Inventory)
Starting date June 2017 (proposed end date: June 2019).
Contact information Andria R. Morielli, ac.atreblau@illeirom
Notes ClinicalTrials.gov identifier: NCT03082495
Country: Canada
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NCT02159157
Trial name or title A randomised, controlled trial to determine the effects of an exercise intervention on physical activity during
chemotherapy for patients with early stage breast cancer
Methods 2-arm RCT (target sample 120)
Participants Breast cancer (adjuvant treatment)
Interventions Exercise prescription aimed at increasingphysical activity by aminimumof 10METhours/week.Motivational
phone calls aimed at encouraging the patient to adhere to their exercise prescription
Outcomes Physical activity (activity log and pedometer data)
Fatigue (FACIT-F questionnaire)
Starting date 9 June 2014 (proposed end date: March 2017). Current status: active not recruiting (last updated 18 May
2017)
Contact information Not provided
Notes ClinicalTrials.gov identifier: NCT02159157
Country: United States.
NCT02454777
Trial name or title High-intensity interval training for stage I-III breast cancer patients
Methods 2-arm RCT (target sample 60)
Participants Breast cancer (neoadjuvant treatment)
Interventions High intensity exercise over 30 minutes, thrice weekly for 8 weeks
Outcomes Feasibility (attendance rate and exercise time completed)
Physical fitness (VO2 peak)
Starting date 29 September 2015 (proposed end date: 29 September 2019). Current status: recruiting (last updated 17 July
2017)
Contact information Christina Dieli-Conwright, PhD, 323-442-2180, cdieli@usc.edu
Notes ClinicalTrials.gov identifier: NCT02454777
Country: United States
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NCT02802826
Trial name or title Studying tailored exercise prescriptions in breast cancer patients (STEPS)
Methods 2-arm RCT (target sample 100)
Participants Breast cancer (neoadjuvant/adjuvant)
Interventions Quote: “Tailored Exercise Prescription Participants will have a discussion on the ’My Exercise Prescription’
booklet on the benefits of increasing levels of physical activity. They will be encouraged to read this in
more detail and guided through its completion. The participant will receive an exercise prescription using
the Pre-Intervention Assessment Tool (PIAT) and following discussion with the participant on a realistic
and achievable starting point.The booklets provided will guide participants through the exercise programme
which is a graduated walking-based activity intervention. Both booklets provide participants with a suggested
starting point for walking distance per week based on their PIAT score as well as motivational and behaviour
change strategies to encourage participation”
Outcomes Physical activity (level of moderate-vigorous physical activity)
Health-related quality of life (Euro-QOL 5D and EORTC QLQ-C30)
Starting date July 2016 (estimated study completion date January 2018). Current status: not yet recruiting (last updated
16 June 2016)
Contact information Contact: Stephen Kihara, +44 (0) 7730609777, s.kihara@lboro
Contact: Fehmidah Munir, +44 (0)1509 228228, f.munir@lboro.ac.uk
Notes ClinicalTrials.gov identifier: NCT02802826
Country: United Kingdom
NCT02999074
Trial name or title Exercise interventions for breast cancer patients undergoing neoadjuvant chemotherapy (BENEFIT)
Methods 3-arm RCT (target sample 342)
Participants Breast cancer (neoadjuvant treatment)
Interventions Resistance exercise: The progressive resistance exercise comprises 8 machine-based exercises, each performed
in 3 sets, 12 repetitions at 60%-80% of one repetition maximum (1-RM)
Aerobic exercise: The aerobic exercise will be performed on a cycle ergometer (or alternatively at a treadmill,
elliptical, rowing ergometer, or combination) progressing from 60% to 70% VO2 max with increasing dura-
tion.
Outcomes Fatigue (Fatigue Assessment Questionnaire, Validated 20-item multidimensional self-assessment question-
naire)
Health-related quality of life (EORTC QLQ-C30)
Starting date January 2016 (proposed end date: January 2020). Current status: recruiting (last updated: 21 December
2016)
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NCT02999074 (Continued)
Contact information Dr Martina E Schmidt, +49 6221 42 2220, email: m.schmidt@dkfz.de
Notes ClinicalTrials.gov identifier: NCT02999074
Country: Germany
NCT03102866
Trial name or title Aerobic and strength training exercise in improving fitness and arm health during and after radiation therapy
in patients with stage II-III breast cancer
Methods 2-arm RCT (target sample 44)
Participants Breast cancer (adjuvant treatment)
Interventions Aerobic and strength training
Quote: “Patients undergo a supervised aerobic and strength training exercise session over 40-60 minutes 3
times weekly for 6 weeks during radiation therapy and for 12 weeks after completion of radiation therapy”
Outcomes Feasibility (number of participants who complete 70% of all exercise sessions throughout the supervised
program during and after radiation therapy based on collected exercise logs)
Physical fitness (6-minute walk test)
Adherence (International Physical Activity Questionnaire and exercise logs)
Quality of life (FACT-B+4)
Starting date 30 August 2017 (proposed end date: 31 December 2019). Current status: recruiting (last updated 6 October
2017)
Contact information Alison Quick, MD, 614-688-7374, Alison.quick@osumc.edu
Notes ClinicalTrials.gov: NCT03102866
Country: United States
NCT03280836
Trial name or title Exercise program in breast cancer patients receiving neoadjuvant chemotherapy (WISER-NET)
Methods 2-arm RCT (target sample 20)
Participants Breast cancer (neoadjuvant)
Interventions Participants will work towards the goal of 75 or more minutes a week of moderate to vigorous exercise.
Participants are provided an exercise toolkit and directed on exercise progression based on personal fitness
level
Outcomes Physical fitness (cardiopulmonary exercise test)
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NCT03280836 (Continued)
Starting date 13 September 2017 (proposed study end date 31 December 2019). Current status: recruiting
Contact information Kathleen M Sturgeon, 717-531-0003 ext 284676, kms99@psu
Notes ClinicalTrials.gov identifier: NCT03280836
Country: United States
NCT03509428
Trial name or title The Wessex Fit-4-Cancer Surgery Trial (WesFit)
Methods 2-arm RCT (target sample 1560)
Participants Major cancer surgery (neoadjuvant treatment)
Interventions An in-hospital transition to a community based StructuredResponsive Exercise-Training Programme (SRETP)
± psychological support (delivered in community/council gyms or cancer support centres). The intervention/
s will be delivered before surgery. Patients receiving neoadjuvant cancer treatments prior to surgery will receive
the intervention during and after these treatments
Outcomes Physical fitness (oxygen uptake at anaerobic threshold and oxygen uptake at peak exercise)
Postoperative morbidity (patients postoperative morbidity survey will be characterised on day 3, 5, 7, and
15). On day of discharge, patient’s surgical complications (if any) will be graded using the Clavien-Dindo
classification of surgical complications This classification is used to assess overall hospital morbidity following
surgical procedures. Patients are graded as 0 (no complications) orGrade I-Vbased on the level of complication,
including the number of organ system involvement. Grade V is defined as death of a patient. A record of
the Comprehensive Complication Index (CCI) - an update of the Clavien-Dindo classification will also be
collected
Physical activity (number of steps, sleep efficiency, metabolic equivalents using a triaxial accelerometer) and
Godin Leisure Time and Exercise questionnaire
Health-related quality of life (EQ-5D-5L an EORTC-QLQ-C30)
Starting date 26 March 2018 (proposed end date: 1 March 2021). Current status: recruiting (last updated 26 April 2018)
Contact information Dr Sandy Jack, PhD, s.jack@soton.ac.uk
Notes ClinicalTrials.gov identifier: NCT03509428
County: United Kingdom
BORG:BORGratingofperceivedexertion
CCI :Comprehensivecomplicationindex
CRT: chemoradiotherapy
EORTC QLQ-C30: European organisation for research and treatment of cancer questionnaire
EQ-5D: standardised instrument for measuring general health status
FACIT-F: Functional assessment of chronic illness therapy - Fatigue
FACT-B+4: Functional assessment of cancer therapy - Breast questionnaire
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MET: Metabolic equivalent threshold
NACRT: Neoadjuvant chemoradiotherapy
PIAT: Pre-Intervention Assessment Tool
SRETP: Structured responsive exercise programme
VO2: Oxygen uptake
VO2 max: Oxygen uptake at maximal capacity
1-RM: 1-repeition maximum
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D A T A A N D A N A L Y S E S
Comparison 1. Intervention versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Aerobic fitness (VO2 max on
cycle ergometer)
2 381 Mean Difference (IV, Random, 95% CI) 0.05 [-0.03, 0.13]
2 Aerobic fitness (6-minute walk
test)
3 146 Mean Difference (IV, Random, 95% CI) 16.79 [-7.39, 40.96]
3 Muscle strength (upper body:
grip strength)
3 419 Mean Difference (IV, Random, 95% CI) 0.73 [-0.86, 2.32]
4 HRQoL (EORTC QLQ-C30
global health status)
3 472 Mean Difference (IV, Random, 95% CI) 2.29 [-1.06, 5.65]
5 HRQoL (EORTC QLQ-C30
cognitive functioning)
3 505 Mean Difference (IV, Random, 95% CI) 3.13 [-0.55, 6.80]
6 HRQoL (EORTC QLQ-C30
social functioning)
3 505 Mean Difference (IV, Random, 95% CI) 3.62 [-0.33, 7.58]
7 HRQoL (EQ-5D utility) 2 263 Mean Difference (IV, Random, 95% CI) 0.01 [-0.05, 0.07]
8 HRQoL (SF-36 general health
perceptions)
2 317 Mean Difference (IV, Random, 95% CI) 0.67 [-3.24, 4.57]
9 HRQoL (SF-36 mental
component scale)
2 317 Mean Difference (IV, Random, 95% CI) 2.58 [0.16, 5.01]
10 HRQoL (SF-36 bodily pain) 2 317 Mean Difference (IV, Fixed, 95% CI) 0.06 [-3.03, 3.15]
11 Fatigue (multidimensional
fatigue inventory)
3 449 Mean Difference (IV, Random, 95% CI) -1.05 [-1.83, -0.28]
12 Fatigue (EORTC QLQ-C30) 3 506 Mean Difference (IV, Random, 95% CI) -5.91 [-10.15, -1.68]
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Analysis 1.1. Comparison 1 Intervention versus control, Outcome 1 Aerobic fitness (VO2 max on cycle
ergometer).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 1 Aerobic fitness (VO2 max on cycle ergometer)
Study or subgroup Favours usual care Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 1.96 (0.5) 117 1.88 (0.5) 37.1 % 0.08 [ -0.05, 0.21 ]
May 2017 83 1.55 (0.3) 63 1.52 (0.3) 62.9 % 0.03 [ -0.07, 0.13 ]
Total (95% CI) 201 180 100.0 % 0.05 [ -0.03, 0.13 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.37, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.22 (P = 0.22)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours usual care Favours exercise
Analysis 1.2. Comparison 1 Intervention versus control, Outcome 2 Aerobic fitness (6-minute walk test).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 2 Aerobic fitness (6-minute walk test)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Haines 2010 27 545 (83) 30 535 (88) 29.6 % 10.00 [ -34.40, 54.40 ]
Husebo 2014 29 644.02 (63.3) 31 628.33 (60.44) 59.4 % 15.69 [ -15.67, 47.05 ]
Reis 2013 12 477.9 (79.2) 17 436.8 (121.4) 10.9 % 41.10 [ -31.96, 114.16 ]
Total (95% CI) 68 78 100.0 % 16.79 [ -7.39, 40.96 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.52, df = 2 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 1.36 (P = 0.17)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours usual care Favours exercise
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Analysis 1.3. Comparison 1 Intervention versus control, Outcome 3 Muscle strength (upper body: grip
strength).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 3 Muscle strength (upper body: grip strength)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Haines 2010 31 24.4 (6.3) 30 24 (5.2) 21.8 % 0.40 [ -2.49, 3.29 ]
May 2017 85 29 (5.7) 67 29.5 (6.6) 35.1 % -0.50 [ -2.49, 1.49 ]
VanWaart 2015 140 29.4 (5.65) 66 27.5 (5.5) 43.1 % 1.90 [ 0.28, 3.52 ]
Total (95% CI) 256 163 100.0 % 0.73 [ -0.86, 2.32 ]
Heterogeneity: Tau2 = 0.84; Chi2 = 3.46, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours usual care Favours exercise
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Analysis 1.4. Comparison 1 Intervention versus control, Outcome 4 HRQoL (EORTC QLQ-C30 global
health status).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 4 HRQoL (EORTC QLQ-C30 global health status)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 67.2 (20.3) 117 63.3 (22.4) 37.6 % 3.90 [ -1.57, 9.37 ]
Haines 2010 33 75.8 (15.2) 32 74 (15.5) 20.2 % 1.80 [ -5.67, 9.27 ]
May 2017 93 70.4 (18.3) 79 69.3 (16.2) 42.2 % 1.10 [ -4.06, 6.26 ]
Total (95% CI) 244 228 100.0 % 2.29 [ -1.06, 5.65 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.55, df = 2 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours usual care Favours exercise
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Analysis 1.5. Comparison 1 Intervention versus control, Outcome 5 HRQoL (EORTC QLQ-C30 cognitive
functioning).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 5 HRQoL (EORTC QLQ-C30 cognitive functioning)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 83.8 (16.7) 117 81.3 (19.8) 61.6 % 2.50 [ -2.19, 7.19 ]
Haines 2010 32 76.6 (29.6) 32 78.6 (23.7) 7.8 % -2.00 [ -15.14, 11.14 ]
VanWaart 2015 140 75.9 (21.9) 66 70.2 (23.1) 30.6 % 5.70 [ -0.95, 12.35 ]
Total (95% CI) 290 215 100.0 % 3.13 [ -0.55, 6.80 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.23, df = 2 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.096)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours usual care Favours exercise
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Analysis 1.6. Comparison 1 Intervention versus control, Outcome 6 HRQoL (EORTC QLQ-C30 social
functioning).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 6 HRQoL (EORTC QLQ-C30 social functioning)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 82.6 (20.5) 117 79.4 (20.8) 56.1 % 3.20 [ -2.08, 8.48 ]
Haines 2010 32 85.4 (20.2) 32 83.9 (16.7) 19.0 % 1.50 [ -7.58, 10.58 ]
VanWaart 2015 140 74.1 (22.2) 66 67.9 (29.1) 24.9 % 6.20 [ -1.73, 14.13 ]
Total (95% CI) 290 215 100.0 % 3.62 [ -0.33, 7.58 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.64, df = 2 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 1.80 (P = 0.072)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Favours usual care Favours exercise
Analysis 1.7. Comparison 1 Intervention versus control, Outcome 7 HRQoL (EQ-5D utility).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 7 HRQoL (EQ-5D utility)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Haines 2010 35 0.8 (0.21) 34 0.83 (0.18) 34.1 % -0.03 [ -0.12, 0.06 ]
May 2017 101 0.84 (0.1) 93 0.81 (0.3) 65.9 % 0.03 [ -0.03, 0.09 ]
Total (95% CI) 136 127 100.0 % 0.01 [ -0.05, 0.07 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 1.10, df = 1 (P = 0.29); I2 =9%
Test for overall effect: Z = 0.34 (P = 0.74)
Test for subgroup differences: Not applicable
-0.2 -0.1 0 0.1 0.2
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Analysis 1.8. Comparison 1 Intervention versus control, Outcome 8 HRQoL (SF-36 general health
perceptions).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 8 HRQoL (SF-36 general health perceptions)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 68.7 (19.7) 117 65.5 (22.4) 38.2 % 3.20 [ -2.20, 8.60 ]
Chandwani 2014 39 47.1 (8.7) 43 48 (8.5) 61.8 % -0.90 [ -4.63, 2.83 ]
Total (95% CI) 157 160 100.0 % 0.67 [ -3.24, 4.57 ]
Heterogeneity: Tau2 = 2.81; Chi2 = 1.50, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 0.34 (P = 0.74)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.9. Comparison 1 Intervention versus control, Outcome 9 HRQoL (SF-36 mental component
scale).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 9 HRQoL (SF-36 mental component scale)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 50.5 (9.4) 117 47.3 (10) 80.1 % 3.20 [ 0.72, 5.68 ]
Chandwani 2014 39 47.2 (13.5) 43 47.1 (10.8) 19.9 % 0.10 [ -5.23, 5.43 ]
Total (95% CI) 157 160 100.0 % 2.58 [ 0.16, 5.01 ]
Heterogeneity: Tau2 = 0.31; Chi2 = 1.07, df = 1 (P = 0.30); I2 =6%
Test for overall effect: Z = 2.09 (P = 0.037)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 1.10. Comparison 1 Intervention versus control, Outcome 10 HRQoL (SF-36 bodily pain).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 10 HRQoL (SF-36 bodily pain)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Adamsen 2009 118 77.6 (20) 117 75.7 (22.7) 31.9 % 1.90 [ -3.57, 7.37 ]
Chandwani 2014 39 44.3 (8.1) 43 45.1 (9.2) 68.1 % -0.80 [ -4.54, 2.94 ]
Total (95% CI) 157 160 100.0 % 0.06 [ -3.03, 3.15 ]
Heterogeneity: Chi2 = 0.64, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Intervention versus control, Outcome 11 Fatigue (multidimensional fatigue
inventory).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 11 Fatigue (multidimensional fatigue inventory)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Haines 2010 36 11.1 (4.2) 34 11.9 (4.5) 14.5 % -0.80 [ -2.84, 1.24 ]
May 2017 91 11.8 (4.2) 82 12.7 (3.7) 43.6 % -0.90 [ -2.08, 0.28 ]
VanWaart 2015 140 13.4 (3.9) 66 14.7 (4.2) 41.9 % -1.30 [ -2.50, -0.10 ]
Total (95% CI) 267 182 100.0 % -1.05 [ -1.83, -0.28 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 2 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 2.65 (P = 0.0080)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Intervention versus control, Outcome 12 Fatigue (EORTC QLQ-C30).
Review: Exercise interventions for people undergoing multimodal cancer treatment that includes surgery
Comparison: 1 Intervention versus control
Outcome: 12 Fatigue (EORTC QLQ-C30)
Study or subgroup Intervention Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Adamsen 2009 118 34.6 (24.3) 117 41 (22.7) 49.6 % -6.40 [ -12.41, -0.39 ]
Haines 2010 33 27.3 (26.4) 32 28.1 (20.5) 13.6 % -0.80 [ -12.27, 10.67 ]
VanWaart 2015 140 44.15 (24.2) 66 51.3 (23.7) 36.8 % -7.15 [ -14.13, -0.17 ]
Total (95% CI) 291 215 100.0 % -5.91 [ -10.15, -1.68 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.91, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0062)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Physical fitness data from individual studies
Exercise group Usual care control group
Outcome mea-
sure
Study Baseline Post-
intervention
Baseline Post-
intervention
P value
Aerobic fitness
Maximal
short exercise ca-
pacity (watts)
VanWaart 2015 263.7 (49.3)a 239.3 (57.3)a 245.0 (48.9) 202.4 (66.5) 0.001
Maximal
short exercise ca-
pacity (watts)
VanWaart 2015 256.1 (48.2)b 221.0 (63.4)b 245.0 (48.9) 202.4 (66.5) 0.34
Endurance
timed test (mins)
VanWaart 2015 13.5 (9.2)a 13.7 (9.0)a 11.4 (8.6) 5.1 (5.4) < 0.001
Endurance
timed test (mins)
VanWaart 2015 12.3 (8.7)b 9.0 (9.0)b 11.4 (8.6) 5.1 (5.4) < 0.001
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Table 1. Physical fitness data from individual studies (Continued)
Step test (steps in
15 secs)
Haines 2010 15.1 (3.5) 15.2 (3.2) 15.8 (4.2) 15.8 (4.2) 0.46
Upper body strength
Chest press (kg) Adamsen 2009 37.9 (15.6) 45.2 (17.9) 40.2 (18.0) 39.7 (17.2) < 0.001
Pull-down test
(kg)
Adamsen 2009 39.6 (14.0) 47.2 (14.4) 42 (16.3) 42.8 (16.1) < 0.001
Elbow flexion
test (Nm)
VanWaart 2015 31.7 (12.5)a 32.0 (13.7)a 29.1 (13.0) 25.2 (12.1) 0.002
Elbow flexion
test (Nm)
VanWaart 2015 30.2 (11.6)b 27.4 (11.9)b 29.1 (13.0) 25.2 (12.1) 0.22
Lower body strength
Leg press test
(kg)
Adamsen 2009 110.8 (30.5) 132.4 (42.3) 107.6 (33.3) 110.4 (36) < 0.001
Leg press test
(kg)
Haines 2010 71.1 (24.3) 81.9 (25.6) 67.4 (15.0) 80.2 (20.5) 0.71
30-sec chair
stand test (times)
VanWaart 2015 19.3 (5.5)a 19.1 (5.0)a 17.7 (4.3) 16.9 (5.3) 0.11
30-sec chair
stand test (times)
VanWaart 2015 18.8 (6.4)b 18.8 (7.0)b 17.7 (4.3) 16.9 (5.3) 0.14
Knee extension
test (Nm)
VanWaart 2015 70.2 (18.6)a 71.4 (17.6)a 65.7 (20.8) 62.3 (22.0) 0.27
Knee extension
test (Nm)
VanWaart 2015 70.3 (20.9)b 66.3 (20.6)b 65.7 (20.8) 62.3 (22.0) 0.10
Right knee ex-
tensor
peak toque at 60
O /s (Nm)
May 2017 102.6 (32) 106.3 (25.9) 106 (27.3) 100.8 (25.5) #
Right knee flexor
peak torque at 60
o/s (Nm)
May 2017 58.6 (20.5) 66.2 (16.8) 59.8 (22.7) 56 (19.9) #
Left knee exten-
sor peak torque
at 60o/s (Nm)
May 2017 96.4 (31.5) 102.2 (31.5) 97.7 (28.3) 93.1 (32.6) #
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Table 1. Physical fitness data from individual studies (Continued)
Left knee flexor
peak torque at 60
o/s (Nm)
May 2017 59.3 (19.7) 67.3 (24) 61.3 (25.3) 58 (2.2) #
Right knee ex-
tensor peak
torque at 180o/s
(Nm)
May 2017 54.1 (22.4) 61.3 (24.2) 58 (23) 57.9 (20) #
Right knee flexor
peak torque at
180o/s (Nm)
May 2017 41.6 (20.3) 48.3 (17.9) 40.8 (20.6) 42.5 (20) #
Left knee exten-
sor peak torque
at 180o/s (Nm)
May 2017 49.1 (20.4) 53.7 (27.5) 60 (21.9) 51 (19.9) #
Left knee flexor
peak torque at
180o/s (Nm)
May 2017 40.5 (19.1) 45.3 (17.6) 39.1 (21.2) 41.8 (18.4) #
Data are presented as mean (SD). a Intervention group 1 (OnTrack group - a supervised programme); b Intervention 2 group (Onco-
Move - home-based programme); # P values were not provided however authors reported that lower body muscle strength for flexion
and extension of both right and left legs were significantly higher than the usual care control groups at 60o/s but not for 180o/s.
Table 2. Health-related quality of life data from individual studies
Exercise group Usual care control group
Outcome mea-
sure
Study Baseline Post-
intervention
Baseline Post-
intervention
P value
EORTC QLQ-C30 questionnaire subscales
EORTC (physi-
cal functioning)
Adamsen 2009 84.7 (14.5) 89 (12.4) 84 (15.7) 86.4 (14.5) 0.09
EORTC (physi-
cal functioning)
Haines 2010 84.9 (14.8) 83.6 (15.8) 91.3 (9.6) 87.5 (10.8) 0.64
EORTC (physi-
cal functioning)
VanWaart 2015 89.4 (10.2)a 80.3 (14.1)a 84.8 (13.8) 68.1 (17.6) < 0.001
EORTC (physi-
cal functioning)
VanWaart 2015 87 (13.4)b 77.8 (17.2)b 84.8 (13.8) 68.1 (17.6) 0.001
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Table 2. Health-related quality of life data from individual studies (Continued)
EORTC (role
functioning)
Adamsen 2009 68.7 (28.4) 74.8 (26.3) 65.6 (28.5) 68.9 (26.5) 0.2
EORTC (role
functioning)
Haines 2010 84.8 (19.2) 80.3 (20.2) 86.4 (21.3) 86.5 (18.7) 0.32
EORTC (emo-
tional function-
ing)
Adamsen 2009 77.6 (12.2) 81.3 (17.2) 75.7 (19.3) 80.6 (17.8) 0.9
EORTC (emo-
tional function-
ing)
Haines 2010 75.4 (19) 81.7 (25.1) 84.3 (15.2) 95.4 (14.2) 0.90
EQ-5D questionnaire
EQ-5D (VAS) Haines 2010 72.6 (15.6) 80.4 (12.7) 77.5 (13.5) 79.3 (14.1) 0.09
SF-36 questionnaire subscales
SF-36 (physical
functioning)
Adamsen 2009 84.3 (13.7) 88.2 (13.2) 83.6 (14.8) 84.3 (16.2) 0.01
SF-36 (physical
functioning)
Chandwani
2014
41.9 (8.1) 43.7 (8.7) 45.9 (7.9) 45.7 (8.6) 0.18
SF-36 (physical
component
scale)
Adamsen 2009 44.2 (8.4) 47.4 (6.7) 44.3 (8.3) 45.1 (8.5) 0.02
SF-36 (physical
component
scale)
Chandwani
2014
41.8 (8.1) 42.3 (8.1) 44.9 (9.2) 44.1 (7.9) 0.47
SF-36 (role
physical)
Adamsen 2009 30.5 (35.2) 46.1 (40.2) 27.1 (35.7) 31.8 (37.6) 0.007
SF-36 (role
physical)
Chandwani
2014
36.8 (9.4) 39.1 (8.7) 38.3 (10.5) 40.8 (9.9) 0.54
SF-36 (role
physical)
Adamsen 2009 30.5 (35.2) 46.1 (40.2) 27.1 (35.7) 31.8 (37.6) 0.007
SF-36 (vitality) Adamsen 2009 57.8 (20.2) 65.5 (18.1) 55.8 (21.1) 55.6 (21.6) < 0.001
SF-36 (role emo-
tional)
Adamsen 2009 56.1 (39) 69.6 (40.1) 58.6 (41.2) 58.7 (41.9) 0.02
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Table 2. Health-related quality of life data from individual studies (Continued)
SF-36 (mental
health)
Adamsen 2009 74 (16.3) 78.6 (15) 72 (16.7) 74.2 (16.1) 0.04
SF-36 (social
functioning)
Adamsen 2009 77 (21.1) 79.7 (22.2) 75.4 (21.8) 76.5 (22) 0.4
WHOWOL questionnaire subscales
Overall quality
of life
Hwang 2008 3.06 (0.75) 3.47 (0.51) 3.30 (0.57) 3.20 (0.77) < 0.001
Overall health Hwang 2008 2.59 (0.87) 2.88 (0.70) 2.55 (0.69) 2.60 (0.88) 0.006
Physical Hwang 2008 11.41 (2.03) 15.00 (2.24) 12.35 (2.30) 12.10 (2.27), < 0.001
Psychological Hwang 2008 11.71 (2.11) 12.71 (2.02) 12.50 (2.65) 12.25 (2.40) 0.001
Social Hwang 2008 12.77 (1.79) 13.71 (1.65) 13.15 (2.46) 12.75 (2.20) < 0.001
Environmental Hwang 2008 12.12 (1.73) 11.82 (3.38) 12.45 (2.42) 12 (2.29) 0.267
FACIT-F questionnaire subscales
Physical well-be-
ing
Reis 2013 23.8 (4.04) 25.2 (2.52) 24.9 (3.39) 24.2 (3.45) NR
Social/family
well-being
Reis 2013 24.3 (4.35) 23.2 (4.06) 23.6 (6.24) 23.2 (5.03) NR
Emotional well-
being
Reis 2013 19.2 (2.37) 20.5 (3.45) 18.9 (3.34) 20.6 (3.15) NR
Functional well-
being
Reis 2013 20.1 (4.91) 22.8 (4.57) 22.3 (5.02) 22.7 (4.9) NR
FACT-G Reis 2013 87.3 (12.58) 91.7 (10.96) 89.8 (12.55) 90.6 (11.06) NR
Outcome mea-
sure not known
Choi 2012 2.69 (0.63) 3.78 (0.71) 2.87 (0.64) 3.16 (0.50) 0.004
Data are reported as mean (SD). a Intervention group 1 (OnTrack group - a supervised programme); b Intervention 2 group (Onco-
Move - home-based programme); EORTC (European Organisation for Research and Treatment of Cancer); SF-36 (Short Form
Health Survey); WHOQOL (World Health Organisation quality of life); FACIT-F (Functional Assessment of Chronic Illness
Therapy-Fatigue); NR (P value not reported).
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Table 3. Fatigue data from individual studies
Exercise group Usual care control group
Outcome mea-
sure
Study Baseline Post-
intervention
Baseline Post-
intervention
P value
Brief
fatigue inventory
questionnaire
Chandwani
2014
3.2 (0.3) 2.9 (0.3) 2.6 (0.3) 3.2 (0.4) 0.03
Schwartz cancer
fatigue scale
Choi 2012 18.27 (5.82) 8.45 (3.33) 15.38 (4.35) 12.08 (4.42) 0.020
Schwartz cancer
fatigue scale
Husebo 2014 10.28 (3.93) 12.01 (4.38) 11.36 (3.56) 13.13 (4.47) NR
FACIT-F ques-
tionnaire
Reis 2013 125.8 (23.51) 136.8 (15.67) 130.8 (20.66) 132.9 (16.85) 0.05
Data are reported as mean (SD). FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue); NR (P value only reported
for the whole sample).
A P P E N D I C E S
Appendix 1. CENTRAL Search strategy
#1 MeSH descriptor: [Neoplasms] explode all trees
#2 (neoplas* or carcinoma* or adenocarcinoma* or malignan* or cancer* or tumor* or tumour*):ti
#3 #1 or #2
#4 MeSH descriptor: [Surgical Procedures, Operative] explode all trees
#5 Any MeSH descriptor with qualifier(s): [Surgery - SU]
#6 (surgery or surgical):ti
#7 #4 or #5 or #6
#8 MeSH descriptor: [Combined Modality Therapy] explode all trees
#9 (combined modality or multimodal* or multi modal*):ti
#10 Any MeSH descriptor with qualifier(s): [Drug therapy - DT]
#11 MeSH descriptor: [Antineoplastic Agents] explode all trees
#12 MeSH descriptor: [Antineoplastic Combined Chemotherapy Protocols] this term only
#13 chemotherap*:ti
#14 MeSH descriptor: [Radiotherapy] explode all trees
#15 Any MeSH descriptor with qualifier(s): [Radiotherapy - RT]
#16 radiotherapy* or irradiat* or radiat*:ti
#17 MeSH descriptor: [Immunotherapy] explode all trees
#18 immunotherap*:ti
#19 (adjuvant or neoadjuvant or neo-adjuvant) near/3 (therap):ti
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#20 #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19
#21 MeSH descriptor: [Exercise] explode all trees
#22 MeSH descriptor: [Exercise Therapy] explode all trees
#23 MeSH descriptor: [Exercise Movement Techniques] explode all trees
#24 MeSH descriptor: [Physical Fitness] this term only
#25 MeSH descriptor: [Physical Endurance] explode all trees
#26 MeSH descriptor: [Muscle Strength] explode all trees
#27 MeSH descriptor: [Muscle Fatigue] explode all trees
#28 (exercise* or movement* or stretch* or aerobic* or anaerobic*):ti
#29 ((resistance near/3 train*) or stamina or (physical near/3 fit*) or ((musc* or neuromusc*) near/3 fatigue)):ti
#30 walk* or swim* or cycl* or run* or yoga or tai chi or pilates:ti
#31 #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30
#32 #3 and #7 and #20 and #31
Appendix 2. MEDLINE Ovid Search strategy
1. exp Neoplasms/
2. (neoplas* or carcinoma* or adenocarcinoma* or malignan* or cancer* or tumor* or tumour*).ti.
3. 1 or 2
4. exp Surgical Procedures, Operative/
5. surgery.fs.
6. (surgery or surgical).ti.
7. 4 or 5 or 6
8. exp Combined Modality Therapy/
9. (combined modality or multimodal* or multi modal*).ti.
10. drug therapy.fs.
11. exp Antineoplastic Agents/
12. Antineoplastic Combined Chemotherapy Protocols/
13. chemotherap*.ti.
14. exp Radiotherapy/
15. radiotherapy.fs.
16. (radiotherap* or irradiat* or radiat*).ti.
17. exp Immunotherapy/
18. immunotherap*.ti.
19. ((adjuvant or neoadjuvant or neo-adjuvant) adj3 therap*).ti.
20. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
21. exp Exercise/
22. exp Exercise Therapy/
23. exp Exercise Movement Techniques/
24. Physical Fitness/
25. exp Physical Endurance/
26. exp Muscle Strength/
27. Muscle Fatigue/
28. (exercis* or movement* or stretch* or aerobic* or anaerobic*).ti.
29. ((resistance adj3 train*) or stamina or (physical adj3 fit*) or ((musc* or neuromisc*) adj3 fatigue)).ti.
30. (walk* or swim* or cycl* or run* or yoga or tai chi or pilates).ti.
31. 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30
32. 3 and 7 and 20 and 31
33. randomized controlled trial.pt.
34. controlled clinical trial.pt.
35. randomized.ab.
36. placebo.ab.
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37. clinical trials as topic.sh.
38. randomly.ab.
39. trial.ti.
40. 33 or 34 or 35 or 36 or 37 or 38 or 39
41. 32 and 40
Key:
mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary
concept word, rare disease supplementary concept word, unique identifier
Appendix 3. Embase Ovid Search Strategy
1. exp neoplasm/
2. (neoplas* or carcinoma* or adenocarcinoma* or malignan* or cancer* or tumor* or tumour*).ti.
3. 1 or 2
4. exp surgery/
5. su.fs.
6. (surgery or surgical).ti.
7. 4 or 5 or 6
8. multimodality cancer therapy/
9. (combined modality or multimodal* or multi modal*).ti.
10. dt.fs.
11. exp chemotherapy/
12. exp antineoplastic agent/
13. chemotherap*.ti.
14. exp radiotherapy/
15. rt.fs.
16. (radiotherap* or irradiat* or radiat*).ti.
17. exp immunotherapy/
18. immunotherap*.ti.
19. ((adjuvant or neoadjuvant or neo-adjuvant) adj3 therap*).ti.
20. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
21. exp exercise/
22. exp kinesiotherapy/
23. fitness/
24. endurance/
25. muscle strength/
26. muscle fatigue/
27. (exercis* or movement* or stretch* or aerobic* or anaerobic*).ti.
28. ((resistance adj3 train*) or stamina or (physical adj3 fit*) or ((musc* or neuromusc*) adj3 fatigue)).ti.
29. (walk* or swim* or cycl* or run* or yoga or tai chi or pilates).ti.
30. 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29
31. 3 and 7 and 20 and 30
32. crossover procedure/
33. double-blind procedure/
34. randomized controlled trial/
35. single-blind procedure/
36. random*.mp.
37. factorial*.mp.
38. (crossover* or cross over* or cross-over*).mp.
39. placebo*.mp.
40. (double* adj blind*).mp.
41. (singl* adj blind*).mp.
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42. assign*.mp.
43. allocat*.mp.
44. volunteer*.mp.
45. 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44
46. 31 and 45
Key:
mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword
ti = title
fs = floating subheading
Appendix 4. Sports Discus Search Strategy
1. expNeoplasm
2. Canc*.tw.
3. Neoplasm*.tw.
4. expTumor
5. Tumo*.tw.
6. expCarcinoma
7. Carcin*.tw.
8. expMalignant
9. expOncology
10. Oncol*tw.
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12. expNeoadjuvant
13. Neoadjuvant*.tw.
14. expChemo
15. Chemo*.tw.
16. expRadiotherapy
17. expCancer treatment
18. 12 or 13 or 14 or 15 or 16 or 17
19. expExercise
20. Exercise*.tw.
21. expFitness
22. Fit*.tw.
23. expOxygen consumption
24. expAerobic
25. Aerobic*.tw.
26. Anaerobic
27. Anaerobic*.tw.
28. 19 or 20 or 21 or 21 or 22 or 23 or 24 or 25 or 26 or 27
29. Surgery
30. Surg*.tw.
31. Surgical (including Anatomy, drainage, mortality, patient, science, stress, wound, ward all terms)
32. 29 or 30 or 31
34. Morb*.tw.
35. Mort*.tw.
36. Recurrence*.tw.
37. Outcom*.tw.
38. 34 or 35 or 36 or 37
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• There were no external sources of support in terms of funding for the review, Other.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We made the following changes between the protocol and review:
• Safety is now a single secondary outcome and feasibility (adherence and compliance) has been omitted as an outcome.
Adherence is now reported in the Characteristics of included studies tables and compliance is reported in incomplete data in the ’Risk
of bias’ tables.
• We added additional study details to the data extraction section.
• We reported data as means (MDs) with standard deviations (SDs) and not as standardised mean differences (SMDs).
• We did not conduct subgroup analyses according to: cancer type (solid and haematological tumours); cancer treatment
(neoadjuvant, adjuvant chemotherapy, adjuvant radiotherapy, immunotherapy); exercise intervention characteristics (frequency,
intensity, timing, type); participant characteristics (gender and age), due to the small number of studies measuring the same outcomes.
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